Indole-functionalized bis-phosphoramidite, preparation method thereof and rhodium-ligand complex

By combining indole functionalized bisphosphonite with rhodium catalyst precursor to form a rhodium-ligand complex, the problems of slow reaction rate, low selectivity and poor stability in olefin hydroformylation are solved. , achieving more efficient and economical catalytic effects.

CN118946574APending Publication Date: 2024-11-12DOW GLOBAL TECHNOLOGIES LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380030781.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-04-13
Filing Date
2023-04-13
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

In the process of hydroformylation of olefins, existing catalysts have problems such as slow reaction rate, low selectivity and poor stability, resulting in low production efficiency and high cost.

Method used

Indole functionalized bisphosphonite is combined with the rhodium catalyst precursor to form a rhodium-ligand complex, which is used for hydroformylation reaction to improve the stability and selectivity of the catalyst.

Benefits of technology

Faster reaction rates, improved linear selectivity and lower catalyst loading are achieved, extending the service life of the catalyst and reducing production costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005061759020000081
    Figure BDA0005061759020000081
  • Figure BDA0005061759020000091
    Figure BDA0005061759020000091
  • Figure BDA0005061759020000101
    Figure BDA0005061759020000101
Patent Text Reader

Abstract

The present invention discloses an indole functionalized bis phosphoramidite having a specific chemical formula. A method for preparing a rhodium-ligand complex includes: combining starting materials comprising: (I) a rhodium catalyst precursor and (II) an indole-functionalized bis phosphoramidite; and optionally, (III) a solvent.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to and all advantages of U.S. Provisional Patent Application No. 63 / 330,571 filed on April 13, 2022, the contents of which are incorporated by reference. Technical Field

[0003] Indole functionalized bisphosphoramidites with a specific chemical formula are disclosed. The indole functionalized bisphosphoramidites are suitable for use as ligands, in particular for preparing rhodium-ligand complexes. A method for preparing rhodium-ligand complexes using indole functionalized bisphosphoramidites is also disclosed. Background Art

[0004] Aldehydes are important intermediates for the synthesis of other functionalized materials such as alcohols, carboxylic acids and amines. The introduction of aldehyde functional groups into olefins, particularly via continuous processes, is important in many industries. Hydroformylation of olefins to prepare aldehydes is highly dependent on catalyst selection in terms of aldehyde selectivity (because straight-chain aldehydes are generally more preferred than branched aldehydes), production rate and catalyst stability. Many conventional catalysts for olefin hydroformylation, even with desired selectivity, have poor stability and deactivate over time, which is undesirable. Summary of the invention

[0005] Indole functionalized bisphosphoramidites are disclosed. The indole functionalized bisphosphoramidites have a formula selected from the group consisting of C1), C2) or C3):

[0006] C1) or

[0007] C2) or

[0008] C3)

[0009] In formulae C1) to C3), R 1 To R 42 are each independently selected from H, a hydrocarbon group, a heteroaryl group, a halogen atom or a heterohydrocarbon group, provided that R 35 To R 42 At least one of them is not H. 1 To Y 12 Each of which is an independently selected indole group of formula (I): Where R 43 To R 47Each of which is an independently selected atom or group selected from the following: H, alkyl, aryl, heteroaryl, alkoxy, acyl, carboxyl, carboxylate, cyano, -SO3H, sulfonate, amino, trifluoromethyl, halogen, a group of the following formula (II), and combinations thereof.

[0010] In the case of indole-functionalized bisphosphoramidites, the following prerequisites apply:

[0011] i)R 44 To R 47 Two or more of may optionally be bonded together to give one or more cyclic moieties; and

[0012] ii) In Y 1 To Y 4 , Y 5 To Y 8 and Y 9 To Y 12 In at least one of each of

[0013] a) R 43 To R 47 At least one of the compounds has the formula (II) Where R 48 To R 52 each of which is an independently selected atom or group selected from H, alkyl, aryl, and alkoxy; or

[0014] b) R 44 To R 47 Two or more of are bonded together to give one or more cyclic moieties; and

[0015] iii) When the indole-functionalized bisphosphoramidite has the formula C1), Y 1 To Y 4 At least one of the R 44 To R 46 At least one of them has formula (II).

[0016] Also disclosed is a method for preparing a rhodium-ligand complex. The method comprises: 1) combining starting materials, the starting materials comprising: (I) a rhodium catalyst precursor and (II) an indole-functionalized bisphosphoramidite; and optionally, (III) a solvent. DETAILED DESCRIPTION

[0017] Indole functionalized bisphosphoramidites are disclosed. The indole functionalized bisphosphoramidites have a formula selected from the group consisting of C1), C2) or C3):

[0018] C1) or

[0019] C2) or

[0020] C3)

[0021] In formulae C1) to C3), R 1 To R 42 are each independently selected from H, a hydrocarbon group, a heteroaryl group, a halogen atom or a heterohydrocarbon group, provided that R 35 To R 42 At least one of them is not H. Because R 35 To R 42 At least one of them is not H, so R 35 To R 42 At least one of is a hydrocarbyl group, a heteroaryl group, a halogen atom or a heterohydrocarbyl group.

[0022] Applicable to R 1 -R 42The hydrocarbon group may be independently linear, branched, cyclic or a combination thereof. Cyclic hydrocarbon groups include aryl groups and saturated or non-conjugated cyclic groups. Cyclic hydrocarbon groups may be monocyclic or polycyclic. Straight and branched hydrocarbon groups may be independently saturated or unsaturated. An example of a combination of straight and cyclic hydrocarbon groups is an aralkyl group. The so-called "substituted" means that one or more hydrogen atoms may be substituted by atoms other than hydrogen (e.g., halogen atoms, such as chlorine, fluorine, bromine, etc.). Examples of suitable alkyl groups include, but are not limited to, the following: methyl, ethyl, propyl (e.g., isopropyl and / or n-propyl), butyl (e.g., isobutyl, n-butyl, tert-butyl and / or sec-butyl), pentyl (e.g., isopentyl, neopentyl and / or tert-pentyl), hexyl, and branched saturated hydrocarbon groups of 6 carbon atoms. Examples of suitable aryl groups include, but are not limited to, the following: phenyl, tolyl, xylyl, naphthyl, benzyl and dimethylphenyl. Suitable alkenyl groups include vinyl, allyl, propenyl, isopropenyl, butenyl, isobutenyl, pentenyl, heptenyl, hexenyl and cyclohexenyl groups. Suitable monovalent halogenated hydrocarbon groups include, but are not limited to, halogenated alkyl groups of 1 to 6 carbon atoms or halogenated aryl groups of 6 to 10 carbon atoms. Examples of suitable halogenated alkyl groups include, but are not limited to, the above-mentioned alkyl groups, wherein one or more hydrogen atoms are replaced by halogen atoms such as F or Cl. For example, fluoromethyl, 2-fluoropropyl, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, 4,4,4,3,3-pentafluorobutyl, 5,5,5,4,4,3,3-heptafluoropentyl, 6,6,6,5,5,4,4,3,3-nonafluorohexyl and 8,8,8,7,7-pentafluorooctyl, 2,2-difluorocyclopropyl, 2,3-difluorocyclobutyl, 3,4-difluorocyclohexyl, and 3,4-difluoro-5-methylcycloheptyl, chloromethyl, chloropropyl, 2-dichlorocyclopropyl and 2,3-dichlorocyclopentyl are examples of suitable haloalkyl groups. Examples of suitable halogenated aryl groups include, but are not limited to, the above-mentioned aryl groups, wherein one or more hydrogen atoms are replaced by halogen atoms such as F or Cl. For example, chlorobenzyl and fluorobenzyl are suitable halogenated aryl groups. Suitable heteroalkyl groups include any of the above-mentioned alkyl groups, but include one or more heteroatoms, such as oxygen, sulfur, nitrogen, etc. Suitable halogen atoms include F, Cl, Br, I, At and Ts, alternatively F, Cl and Br, alternatively Cl.

[0023] Y 1 To Y 12 Each of which is an independently selected indole group of formula (I):

[0024] Where R 43 To R 47Each of is an independently selected atom or group selected from the following: H, alkyl, aryl, heteroaryl, alkoxy, acyl, carboxyl, carboxylate, cyano, -S03H, sulfonate, amino, trifluoromethyl, halogen, a group of the following formula (II), and combinations thereof. Examples of alkyl, aryl, and heteroaryl are as described above. In the above formula, the single line attached to N represents a bond because the above formula is monovalent.

[0025] In the case of indole-functionalized bisphosphoramidites, the following prerequisites apply:

[0026] i)R 44 To R 47 Two or more of may optionally be bonded together to give one or more cyclic moieties; and

[0027] ii) In Y 1 To Y 4 , Y 5 To Y 8 and Y 9 To Y 12 In at least one of each of

[0028] a) R 43 To R 47 At least one of the compounds has the formula (II) Where R 48 To R 52 each of which is an independently selected atom or group selected from H, alkyl, aryl, and alkoxy; or

[0029] b) R 44 To R 47 Two or more of are bonded together to give one or more cyclic moieties; and

[0030] iii) When the indole-functionalized bisphosphoramidite has the formula C1), Y 1 To Y 4 At least one of the R 44 To R 46 At least one of them has formula (II).

[0031] All three of the preconditions (i) to (iii) apply to the indole functionalized bisphosphoramidite. However, only one of the preconditions (ii)(a) and (ii)(b) need apply, i.e., both (ii)(a) and (ii)(b) are not essential, as these are alternative requirements, and thus only one of (ii)(a) or (ii)(b) is required.

[0032] Although all three of preconditions (i) to (iii) are applicable to indole functionalized bisphosphoramidites, precondition (iii) is only invoked when the indole functionalized bisphosphoramidite has formula C1). Preconditions (ii)(a) and (iii) are related to each other but are applicable to different embodiments of the indole functionalized bisphosphoramidite. As will be appreciated by those skilled in the art from preconditions (i) to (iii), when the indole functionalized bisphosphoramidite has formula C1), Y 1 To Y 4 At least one of the R 44 To R 46 At least one of the indole functionalized bisphosphoramidite has the formula (II) based on the precondition (iii). However, when the indole functionalized bisphosphoramidite has the formula C2) or C3), then based on the precondition (ii), R 43 To R 47 At least one of them has formula (II) (ie, prerequisite (ii) (a)), or R 44 To R 47 Two or more of the indole functionalized bisphosphoramidite are bonded together to give one or more cyclic moieties (ie, prerequisite (ii) (b)). Based on prerequisite (iii), when the indole functionalized bisphosphoramidite has formula C1), Y 1 To Y 4 At least one of the R 43 Still can have formula (II), as long as Y 1 To Y 4 At least one of the R 44 To R 46 At least one of them may also have the formula (II).

[0033] In certain embodiments, Formula (II) is independently selected from one of the following formulae:

[0034]

[0035] In the above formula, the single line attached to each aryl moiety represents the bond in the indole group of formula (I), rather than the methyl group, since the above formula is monovalent. The methyl group is explicitly labeled as such.

[0036] When R 43 To R 47 When at least one of the following has formula (II) based on precondition (ii) (a), based on the selection of formula (II), Y 1 To Y 12 Each of may be independently selected from the group consisting of the following (subject to the proviso, and wherein Me refers to methyl, OMe refers to methoxy, Ph refers to phenyl, and tBu refers to tert-butyl):

[0037]

[0038]

[0039]

[0040] Alternatively, when R 44 To R 47 When two or more of the above are bonded together to give one or more cyclic moieties based on precondition (ii)(b), Y 1 To Y 12 An example is:

[0041]

[0042] In certain embodiments where precondition (ii)(a) is true, R 44 To R 46 At least one of has formula (II). In a specific embodiment where precondition (ii)(a) is true, R 44 In other embodiments where precondition (ii)(a) is true, R 45 In other embodiments where precondition (ii)(a) is true, R 46 It has the formula (II).

[0043] In these or other embodiments, the indole-functionalized bisphosphoramidite has the formula C1) and R 1 To R 20 Each of is H. In other embodiments, the indole-functionalized bisphosphoramidite has formula C2), and R 21 To R 34 Each of is H. In other embodiments, the indole-functionalized bisphosphoramidite has formula C3), and R 35 and R 42 Each of is H, and R 36 To R 41 Each of is methyl.

[0044] In one embodiment, the indole functionalized bisphosphoramidite has formula C1). In another embodiment, the indole functionalized bisphosphoramidite has formula C2). In yet another embodiment, the indole functionalized bisphosphoramidite has formula C3).

[0045] By way of example, when the indole-functionalized bisphosphoramidite has the formula C1), and when R 1 To R 20 When each is H, the indole-functionalized bisphosphoramidite of formula C1) becomes as follows:

[0046]

[0047] where Y 1 To Y 4 are independently selected and defined as above.

[0048] For example, when the indole-functionalized bisphosphoramidite has the formula C2), and when R 21 To R 34 When each is H, the indole-functionalized bisphosphoramidite of formula C2) becomes as follows:

[0049]

[0050] where Y 5 To Y 8 are independently selected and defined as above.

[0051] As yet another example, when the indole-functionalized bisphosphoramidite has the formula (C3), R 35 and R 42 is H, and R 36 To R 41 When each of is methyl, the indole-functionalized bisphosphoramidite of formula (C3) becomes as follows:

[0052]

[0053] where Y 9 To Y 12 are independently selected and defined as above.

[0054] In certain embodiments, the indole-functionalized bisphosphoramidite has the formula C1), provided that conditions (i), (ii) (a), and (iii) apply, and R is selected 1 To R 20 and Y 1 To Y 4 , such that the indole-functionalized bisphosphoramidite is selected from the group consisting of those in Table 1 below (L1 to L9 or L13).

[0055] Table 1: Some types of indole-functionalized bisphosphoramidites

[0056]

[0057]

[0058]

[0059]

[0060]

[0061]

[0062]

[0063]

[0064]

[0065]

[0066] Those skilled in the art understand how to prepare the above-mentioned indole functionalized bisphosphoramidites according to the examples herein, and understand how to replace certain starting materials to modify the desired structure under similar reaction schemes. In addition, the general method of preparing the ligand structure is disclosed in U.S. Patent No. 9,795,952 to Diebolt et al., which is incorporated herein by reference in its entirety, and which can be modified by those skilled in the art with reference to the teachings herein to prepare the above-mentioned indole functionalized bisphosphoramidites.

[0067] In another embodiment, the indole functionalized bisphosphoramidite has the formula C1), provided that conditions (i), (ii) (b) and (iii) apply, and R is selected 1 To R 20 and Y 1 To Y 4 , such that the indole-functionalized bisphosphoramidite has the following formula (L12) in Table 2 below.

[0068] Table 2: Types of indole-functionalized bisphosphoramidites

[0069]

[0070] Those skilled in the art understand how to prepare the above-mentioned indole functionalized bisphosphoramidites according to the examples herein, and understand how to replace certain starting materials to modify the desired structure under similar reaction schemes. In addition, the general method of preparing the ligand structure is disclosed in U.S. Patent No. 9,795,952 to Diebolt et al., which is incorporated herein by reference in its entirety, and which can be modified by those skilled in the art with reference to the teachings herein to prepare the above-mentioned indole functionalized bisphosphoramidites.

[0071] In other embodiments, the indole-functionalized bisphosphoramidite has formula C2), and R is selected 21 To R 34 and Y 5 To Y 8 , such that the indole-functionalized bisphosphoramidite has the following formula (L11) in Table 3 below.

[0072] Table 3: Types of indole-functionalized bisphosphoramidites

[0073]

[0074] Those skilled in the art understand how to prepare the above-mentioned indole functionalized bisphosphoramidites according to the examples herein, and understand how to replace certain starting materials to modify the desired structure under similar reaction schemes. In addition, the general method of preparing the ligand structure is disclosed in U.S. Patent No. 9,795,952 to Diebolt et al., which is incorporated herein by reference in its entirety, and which can be modified by those skilled in the art with reference to the teachings herein to prepare the above-mentioned indole functionalized bisphosphoramidites.

[0075] In other embodiments, the indole-functionalized bisphosphoramidite has formula C3), and R is selected 35 To R 42 and Y 9 To Y 12 , such that the indole-functionalized bisphosphoramidite has the following formula (L10) in Table 4 below.

[0076] Table 4: Types of indole-functionalized bisphosphoramidites

[0077]

[0078] Those skilled in the art understand how to prepare the above-mentioned indole functionalized bisphosphoramidites according to the examples herein, and understand how to replace certain starting materials to modify the desired structure under similar reaction schemes. In addition, the general method of preparing the ligand structure is disclosed in U.S. Patent No. 9,795,952 to Diebolt et al., which is incorporated herein by reference in its entirety, and which can be modified by those skilled in the art with reference to the teachings herein to prepare the above-mentioned indole functionalized bisphosphoramidites.

[0079] A method for preparing a rhodium-ligand complex is also disclosed. The method comprises: combining starting materials, the starting materials comprising: (I) a rhodium catalyst precursor and (II) an indole-functionalized bisphosphoramidite; and optionally, (III) a solvent. The rhodium-ligand complex is formed from starting materials (I) and (II), optionally in starting material (III).

[0080] For example, the rhodium-ligand complex can be prepared by a process comprising combining a rhodium catalyst precursor and the above-described indole-functionalized bisphosphoramidite under conditions to form a complex. Alternatively, the rhodium-ligand complex can be formed in situ by introducing the rhodium catalyst precursor into the reaction medium and introducing the indole-functionalized bisphosphoramidite into the reaction medium (e.g., before, during, and / or after the introduction of the rhodium catalyst precursor) to form the rhodium-ligand complex in situ, such as during a hydroformylation reaction, as described below. Examples of rhodium catalyst precursors are rhodium dicarbonyl acetylacetonate, Rh2O3, Rh4(CO) 12 、Rh6(CO) 16 and Rh(NO3)3. Additional methods for preparing certain indole-functionalized bisphosphoramidites are described in the Examples appended herein.

[0081] For example, a rhodium catalyst precursor such as rhodium dicarbonyl acetylacetonate, optionally starting material (D), a solvent, and an indole-functionalized bisphosphoramidite may be combined, for example, by any convenient means such as mixing.

[0082] The rhodium-ligand complex is particularly suitable for use in a hydroformylation process involving olefins. The hydroformylation process described herein employs a starting material comprising: (A) a gas comprising hydrogen and carbon monoxide, (B) an olefin, and (C) a rhodium-ligand complex catalyst. The starting material may also optionally comprise (D) a solvent.

[0083] Starting material (A), i.e. the gas used in the hydroformylation process, comprises carbon monoxide (CO) and hydrogen (H2). For example, the gas may be synthesis gas. As used herein, "synthesis gas" (from synthesis gas) refers to a gas mixture comprising varying amounts of CO and H2. Production methods are well known and include, for example: (1) steam reforming and partial oxidation of natural gas or liquid hydrocarbons, and (2) gasification of coal and / or biomass. CO and H2 are typically the main components of synthesis gas, but synthesis gas may contain carbon dioxide and inert gases such as CH4, N2 and Ar. The molar ratio of H2 relative to CO (H2:CO molar ratio) varies widely, but is typically in the range of 1:100 to 100:1, alternatively 1:10 to 10:1. Synthesis gas is commercially available and is typically used as a fuel source or as an intermediate for the production of other chemicals. Alternatively, CO and H2 from other sources (i.e., in addition to synthesis gas) may be used as starting material (A) herein. Alternatively, the H2:CO molar ratio in the starting material (A) used herein may be 3:1 to 1:3, alternatively 2:1 to 1:2, alternatively 1:1.

[0084] The starting material (B) olefin is not limited. The starting material (B) may be substituted or unsubstituted and may be selected from optically active (prochiral and chiral) and non-optically active (achiral) olefinically unsaturated compounds containing 2 to 40, alternatively 2 to 30, alternatively 2 to 20 carbon atoms and one or more carbon-carbon double bonds (C=C).

[0085] The starting material (B) may be terminally or internally unsaturated and have a linear, branched or cyclic structure. Olefin mixtures may also be employed, such as those obtained from the oligomerization of propylene, butene and isobutylene (such as so-called dimerization, trimerization or tetramerization), and mixed butenes, such as raffinate I and raffinate II known to those skilled in the art.

[0086] Illustrative examples of alpha and internal olefins suitable for the starting material (B) include ethylene, propylene, 1-butene, 1-pentene, 1-hexene, 1-heptene, 1-octene, 1-nonene, 1-decene, 1-undecene, 1-dodecene, 1-tridecene, 1-tetradecene, 1-pentadecene, 1-hexadecene, 1-heptadecene, 1-octadecene, 1-nonadecene, 1-eicosene, 2-butene, 2-methylpropene (isobutylene), 2-Methylbutene, 2-pentene, 2-hexene, 3-hexane, 2-heptene, 2-octene, cyclohexene, propylene dimer, propylene trimer, propylene tetramer, butadiene, piperylene, isoprene, 2-ethyl-1-hexene, styrene, 4-methylstyrene, 4-isopropylstyrene, 4-tert-butylstyrene, α-methylstyrene, 4-tert-butyl-α-methylstyrene, 1,3-diisopropenylbenzene, 3-phenyl-1-propylene, 1, 4-hexadiene, 1,7-octadiene, 3-cyclohexyl-1-butene, etc., as well as 1,3-diene, butadiene, alkyl alkenoates (e.g., methyl pentenoate); alkenyl alkanoates, alkenyl alkyl ethers, alkenols (e.g., pentenols); alkenals (e.g., pentenals); such substances include allyl alcohol, allyl butyrate, hex-1-en-4-ol, oct-1-en-4-ol, vinyl acetate, allyl acetate, 3-butylene acetate, ethyl propionate The present invention relates to olefinic acid, olefin esters, allyl propionate, methyl methacrylate, vinyl ethyl ether, vinyl methyl ether, allyl ethyl ether, n-propyl 7-octenoate, 3-butenenitrile, 5-hexenamide, eugenol, isoeugenol, safrole, isosafrole, anethole, 4-allylanisole, indene, limonene, β-pinene, dicyclopentadiene, cyclooctadiene, camphene, linalool, oleic acid and esters thereof (such as methyl oleate), and homologous unsaturated fatty acids and unsaturated fatty acid esters. Examples of suitable substituted and unsubstituted olefin starting materials include those olefin compounds described in the following document: Kirk-Othmer, Encyclopedia of Chemical Technology, Fourth Edition, 1996, the relevant parts of which are incorporated herein by reference.

[0087] (C) The rhodium-ligand complex is as described above and may optionally be introduced into the reactor together with an excess of indole-functionalized bisphosphoramidite. Alternatively, the rhodium catalyst precursor, (D) solvent and ligand may be combined in the reactor with the starting materials (A) and / or (B), the olefin; and the rhodium-ligand complex may be formed in situ. The relative amounts of ligand and rhodium catalyst precursor are sufficient to provide an indole-functionalized bisphosphoramidite / Rh molar ratio of 10 / 1 to 1 / 1, alternatively 5 / 1 to 1 / 1, alternatively 3 / 1 to 1 / 1, alternatively 2.5 / 1 to 1.5 / 1. In addition to the rhodium-ligand complex, an excess (e.g., uncomplexed) indole-functionalized bisphosphoramidite may be present in the reaction mixture. The excess indole-functionalized bisphosphoramidite may be the same or different from the indole-functionalized bisphosphoramidite in the rhodium-ligand complex.

[0088] The amount of (C) rhodium-ligand complex catalyst (catalyst) is sufficient to catalyze the hydroformylation of (B) olefin. The exact amount of catalyst will depend on various factors, including the type of olefin selected for starting material (B), its exact vinyl content and reaction conditions such as the temperature and pressure of starting material (A). However, based on the weight of (B) olefin, the amount of (C) catalyst can be sufficient to provide at least 0.1ppm, alternatively 0.15ppm, alternatively 0.2ppm, alternatively 0.25ppm and alternatively 0.5ppm of rhodium metal concentration. At the same time, based on the same benchmark, the amount of (C) catalyst can be sufficient to provide at most 300ppm, alternatively at most 100ppm, alternatively at most 20ppm and alternatively at most 5ppm of rhodium metal concentration. Alternatively, the amount of (C) catalyst may be sufficient to provide 0.1 ppm to 300 ppm, alternatively 0.2 ppm to 100 ppm, alternatively 0.25 ppm to 20 ppm, alternatively 0.5 ppm to 5 ppm based on the weight of (B) olefin.

[0089] Hydroformylation process reaction can be carried out without additional solvent. Alternatively, the hydroformylation method reaction can be carried out with a solvent, for example to promote mixing and / or delivering one or more of the above-mentioned starting materials, such as (C) catalyst and / or starting material (B). Examples of solvents include aliphatic or aromatic hydrocarbons of soluble starting materials, such as toluene, xylene, benzene, hexane, heptane, decane, cyclohexane or a combination of two or more thereof. Additional solvents include THF, dibutyl ether, diglyme and Texanol. Without wishing to be bound by theory, it is believed that solvents can be used to reduce the viscosity of starting materials. The amount of solvent is not critical, however, when present, based on the weight of starting material (B) olefins, the amount of solvent can be 5% to 70%.

[0090] In the methods described herein, step 1) is performed at a relatively low temperature. For example, step 1) may be performed at a temperature of at least 30°C, alternatively at least 50°C, and alternatively at least 70°C. At the same time, the temperature in step 1) may be as high as 150°C; alternatively up to 100°C; alternatively up to 90°C, and alternatively up to 80°C. Without wishing to be bound by theory, it is believed that lower temperatures, such as 30°C to 90°C, alternatively 40°C to 90°C, alternatively 50°C to 90°C, alternatively 60°C to 90°C, alternatively 70°C to 90°C, alternatively 80°C to 90°C, alternatively 30°C to 60°C, alternatively 50°C to 60°C, may be desirable to achieve high selectivity and ligand stability.

[0091] In the methods described herein, step 1) may be performed at a pressure of at least 101 kPa (ambient), alternatively at least 206 kPa (30 psi), and alternatively at least 344 kPa (50 psi). At the same time, the pressure in step 1) may be as high as 6,895 kPa (1,000 psi), alternatively up to 1,379 kPa (200 psi), alternatively up to 1000 kPa (145 psi), and alternatively up to 689 kPa (100 psi). Alternatively, step 1) may be performed at 101 kPa to 6,895 kPa; alternatively 344 kPa to 1,379 kPa; alternatively 101 kPa to 1,000 kPa; and alternatively 344 kPa to 689 kPa. Without wishing to be bound by theory, it is believed that the use of relatively low pressures, eg, <6,895 kPa, in the processes herein may be beneficial; the ligands described herein allow for low pressure hydroformylation processes which have the benefits of lower cost and better safety than high pressure hydroformylation processes.

[0092] The hydroformylation process can be carried out in batch, semi-batch or continuous mode using one or more suitable reactors such as fixed bed reactors, fluidized bed reactors, continuous stirred tank reactors (CSTR) or slurry reactors. The selection of (B) olefins and (C) catalysts and whether (D) solvents are used may affect the size and type of reactor used. One reactor can be used, or two or more different reactors. The hydroformylation process can be carried out in one or more steps, which can be influenced by balancing capital costs and achieving high catalyst selectivity, activity, service life and ease of operation, as well as the reactivity of the specific starting materials and the selected reaction conditions and desired products.

[0093] Alternatively, the hydroformylation process may be carried out in a continuous manner. For example, the process used may be as described in US Pat. No. 10,023,516, except that the catalyst therein is replaced by (C) a rhodium-ligand complex as described herein.

[0094] Step 1) of the hydroformylation process forms a reaction fluid comprising an aldehyde functional compound. The reaction fluid may also contain additional materials, such as those intentionally employed or formed in situ during step 1) of the process. Examples of such materials that may also be present include unreacted (B) olefins, unreacted (A) carbon monoxide and hydrogen, and / or byproducts formed in situ, such as indole functionalized bisphosphoramidite degradation products and adducts thereof, and high boiling liquid aldehyde condensation byproducts, and (D) solvents (if employed). The term "indole functionalized bisphosphoramidite degradation products" includes, but is not limited to, any and all compounds produced by one or more chemical transformations of at least one ligand molecule used in the process.

[0095] The hydroformylation process may also include one or more additional steps, such as: 2) recovering the (C) rhodium-ligand complex from the reaction fluid containing the aldehyde-functional compound. Recovery of the (C) rhodium-ligand complex may be performed by methods known in the art, including but not limited to adsorption and / or membrane separation (e.g., nanofiltration). Suitable recovery methods are described, for example, in U.S. Pat. No. 5,681,473 to Miller et al., U.S. Pat. No. 8,748,643 to Priske et al., and U.S. Pat. No. 10,155,200 to Geilen et al.

[0096] However, one benefit of the method described herein is that the (C) catalyst does not need to be removed and recycled. Due to the low level of Rh required, it may be more cost-effective not to recover and recycle the (C) catalyst; and the aldehyde functional compound produced by the method may be stable even when the catalyst is not removed. Therefore, alternatively, the above method can be carried out without step 2).

[0097] Alternatively, the hydroformylation process may further include 3) purification of the reaction product. For example, the aldehyde functional compound may be separated from the additional materials described above by any convenient means such as stripping and / or distillation, optionally under reduced pressure.

[0098] The following examples are intended to illustrate the present invention and should not be viewed in any way as limiting the scope of the present invention.

[0099] Certain components utilized in the Examples are listed in Table 5 below.

[0100] Table 5: Components / compounds used

[0101] Components Chemical Class / Description Solvent 1 <![CDATA[Toluene (C7H8)]]> Solvent 2 Tetraethylene glycol dimethyl ether Olefins Propylene

[0102]

[0103]

[0104]

[0105] The product structure and composition are 1 H. 13 C and 29 Si Nuclear Magnetic Resonance (NMR) Support.

[0106] 1 H. 13 C and 29 Si NMR spectra were measured on a Varian 400-NMR spectrometer (400 MHz, 1 H) record. 1 H and 13 The chemical shifts (δ) of the C spectra were referenced to internal solvent resonances and reported relative to tetramethylsilane. Acquired using Perkin-Elmer ChemDraw version 18.2.0.48 software 1 H and 13 Predicted chemical shifts for C spectra.

[0107] Preparation Example: Ligand Synthesis

[0108] Unless otherwise mentioned, all solvents and reagents were obtained from commercial sources and used as received. Anhydrous toluene, hexane, tetrahydrofuran, and diethyl ether were purified by passing them through activated alumina. Solvents used for experiments in a nitrogen-filled glove box were purified by storing them in activated The HPLC-MS analysis was performed on a 50 μm HPLC-MS column using a 1.5 μm HPLC-MS column. The HPLC-MS analysis was performed on a 1.5 μm HPLC-MS column using a 1.5 μm HPLC-MS column. The HPLC-MS analysis was performed on a 50 ... 1 H NMR data are reported as follows: Chemical shift (multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, p = quintet, sex = sextet, sept = septet and m = multiplet), integration and assignment). Reported in ppm with reference to deuterated solvent. 1Chemical shifts of H NMR data. 13 C NMR data 1 Chemical shifts are reported in ppm relative to tetramethylsilane (TMS, delta scale) using residual carbon in deuterated solvent as reference. 31 P NMR data Chemical shifts Chemical shifts (referenced to H3PO4).

[0109] Preparation Example 1: Ligand 1

[0110]

[0111] In N2 purged glove box, 2.0g (12.45mmol) 1H-indole-6-boric acid (1a), 0.2g (0.24mmol) precatalyst and 85mL THF were loaded into 220mL wide-mouth bottle. The mixture was stirred at room temperature for 5 minutes. After 5 minutes, 2.34g (11.75mmol) 2-bromo-1,3,5-trimethylbenzene 2a was added to the solution, and then about 70mL potassium phosphate aqueous solution (70mL H2O in 7.48g (35.26mmol)) was added. Then the reaction mixture was stirred at room temperature overnight. On the second day, the reactant was taken out from the glove box. Ether (80mL) was added to the reaction mixture, and then the mixture was transferred to a separating funnel. The organic layer was separated, and the aqueous layer was further washed with 80mL of ether (2X). Combined organic layers, and MgSO4 and activated carbon were dried. Then the ether solution was filtered by a silica plug, and the solvent was removed under reduced pressure to obtain a white solid. The solid was washed with cold hexane and dried under vacuum. Yield: 2.70 g (97%). 1 H NMR (400MHz, C6D6) δ7.68(dq,J=8.0,0.7Hz,1H),6.99(ddd,J=8.1,1.4,0.6Hz,1H),6.97–6.91(m,3H),6.72(s ,1H),6.59(ddd,J=3.1,2.4,0.6Hz,1H),6.50(ddd,J=3.1,2.1,0.9Hz,1H),2.25(s,3H),2.16(d,J=0.7Hz,6H). 13 C{ 1 H}NMR(101MHz,C2D6)δ140.62,136.58,136.46,136.25,135.47,128.54,127.16,124.18,121.86,121.13,111.73,102.68,21.21.

[0112]

[0113] In a glove box purged with N2, phosphorus trichloride (0.36g, 2.65mmol) and triethylamine (1.08g, 10.62mmol) were added to 75mL toluene in a 110mL glass jar. The solution was placed in a glove box freezer (-35°C) for 1 hour to cool. Indole 3a (1.25g, 5.31mmol) was weighed into a 20mL vial and dissolved in 10mL toluene. The indole solution was also cooled in a glove box freezer for 1 hour. Both solutions were removed from the freezer, and the cold indole solution was added dropwise to the cold PCl3 / Net3 solution under stirring. A large amount of white precipitates were formed during the addition. The reaction mixture was stirred at room temperature overnight, and the reaction was monitored from beginning to end. Once completed, the reactant was filtered through Celite to remove triethylammonium chloride, and the light yellow filtrate was evacuated to dryness. It is believed that material 4b is pure enough to carry out the next step of the reaction. 31 P{ 1 H}NMR(162MHz, CDCl3)δ103.9(s)ppm.

[0114]

[0115] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 0.15 g, 0.51 mmol) and bis[6-(2,4,6-trimethyl-phenyl)-1H-indolyl]chlorophosphine (4a, 0.545 g, 1.01 mmol) were weighed into a 110 mL glass jar and dissolved in 25 mL toluene to produce a red-yellow solution and kept in a refrigerator for one hour (-35 ° C). Triethylamine (0.2 g) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature and slowly warmed to 50 ° C overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and washed with water by evaporation. 31 P NMR spectroscopy analysis. 31 P NMR showed complete conversion to the desired bisphosphoramidite product with some cyclic phosphoramidite and triphosphoramidite products.The solid was purified by neutral alumina chromatography to afford 200 mg (30% yield) of product (ligand L1). 1H NMR (400MHz, CDCl3) δ7.66–7.54(m,4H),7.26–7.24(m,2H),7.12(s,2H),7.01–6.92(m,12H),6.91–6.88(m,4H),6.88–6.82(m,4H),6.51–6.37( m,4H),2.80–2.55(m,4H),2.46–2.41(m,12H),2.38(m,2H),2.21(m,2H) ,2.00(s,6H),1.90(s,6H),1.79(s,6H),1.69(s,6H),1.62–1.32(m,8H). 31 P{ 1 H}NMR(162MHz,C6D6)δ107.18(s)ppm.

[0116] Preparation Example 2: Ligand 2

[0117]

[0118] In N2 purged glove box, 2.06g (12.8mmol) 1H-indole-6-boric acid (1a), 0.22g (0.25mmol) precatalyst and 80mL THF were loaded into a 220mL wide-mouth bottle. The mixture was stirred at room temperature for 5 minutes. After 5 minutes, 3.54mL (14.1mmol) 1-bromo-3,5-dimethylbenzene 2b was added to the solution, followed by addition of about 60mL potassium phosphate tripotassium aqueous solution (60mL H2O in 7.92g (37.3mmol)). The reaction mixture was then stirred at room temperature overnight. The next day, the reactant was taken out from the glove box. Ether (80mL) was added to the reaction mixture, and the mixture was then transferred to a separating funnel. The organic layer was separated, and the aqueous layer was further washed with 80mL of ether (2X). The organic layers were combined, and dried on MgSO4 and activated carbon. The ether solution was then filtered through a basic alumina plug, and the solvent was removed under reduced pressure to obtain a white solid. The solid was washed with cold hexane and dried under vacuum. Yield: 2.03 g (6.23 mmol, 49.4%). 1H NMR (400 MHz, CDCl3) δ 8.15 (br s, 1H, NH), 7.65 (dt, J = 8.2, 0.7 Hz, 1H, Ar-H), 7.57 (dt, J = 1.6, 0.8 Hz, 1H, Ar-H), 7.35 (dd, J = 8.2, 1.6 Hz, 1H, Ar-H), 7.27-7.24 (m, 2H, Ar-H), 7.21 (dd, J = 3.2, 2.4 Hz, 1H, Ar-H), 6.96-6.94 (m, 1H, Ar-H), 6.55 (ddd, J = 3.1, 2.0, 1.0, Hz, Ar-H), 2.37 (overlapping singlet, 6H, CH3). 13 C{ 1 H}NMR(101MHz, CDCl3)δ142.5(s),138.4(s),136.5(s),136.0(s),128.5(s),127. 3(s),125.6(s),124.9(s),121.0(s),120.1(s),109.7(s),102.8(s),21.7(s)ppm.

[0119]

[0120] In a N2 purged glove box, phosphorus trichloride (0.34 mL, 3.9 mmol) and triethylamine (2.5 mL, 18 mmol) were added to 70 mL toluene in a 110 mL glass jar. The solution was placed in a glove box freezer (-35 ° C) for 1 hour to cool. 6-(3,5-dimethylphenyl)-1H-indole 3b (1.75 g) was weighed into a 20 mL jar and dissolved in 15 mL toluene. The indole solution was also cooled in the glove box freezer for 1 hour. Both solutions were removed from the freezer and the cold indole solution was added dropwise to the cold PCl3 / Net3 solution under stirring. A large amount of white precipitate was formed during the addition. The reaction mixture was warmed to room temperature and stirred overnight. The next day, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis. The spectrum showed the formation of the desired product at δ 103 ppm. The reaction mixture was filtered through Celite to remove triethylammonium chloride, and the yellow filtrate was pumped to dryness. Yield: 1.56 g (3.08 mmol, 78.0%). Note: By 31 P NMR found 87% purity. Material 4b was deemed pure enough to proceed to the next step of the reaction. 31 P{ 1 H}NMR(162MHz,C6D6)δ104.7(s)ppm.

[0121]

[0122] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 0.45 g, 1.5 mmol) and bis[6-(3,5-dimethylphenyl)-1H-indolyl] chlorophosphine (4b, 1.55 g, 3.06 mmol) were weighed into a 110 mL glass jar and dissolved in 80 mL toluene to produce a yellow solution. Under stirring, triethylamine (1 mL, 7 mmol) was added dropwise to the solution, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and the mixture was stirred for 10 min. The reaction mixture was stirred for 10 min. The mixture was stirred for 20 min. The mixture was stirred for 30 min. The mixture was stirred for 10 min. The mixture was stirred for 20 min. The mixture was stirred for 30 min. 31 P NMR spectroscopy analysis. Spectrum display is converted into the desired product (L2, 105ppm) of about 60% purity. The reaction mixture is filtered through Celite to remove triethylammonium chloride, and the yellow filtrate is evacuated to dryness. The material is loaded on a 24g gold silica column and eluted with 10 times of column volumes of pure hexane. Chloroform is then introduced into the eluent, gradually increased to 20% chloroform (80% hexane) in five column volumes. The solvent mixture (20 / 80) is used for another 10 column volumes. A total of 520mg pure material ligand L2 (white powder) is obtained. Total yield: 0.520g (0.421mmol, 27.5%). 1 H NMR (400MHz, C6D2) δ7.88(s,4H,Ar-CH),7.47(t,J=7.8Hz,4H,Ar-CH),7.39(dt,J=8.2,1.6Hz,4H,Ar-CH),7. 22(dt,J=3.0,1.3Hz,2H,Ar-CH),7.18-7.14(m,8H,Ar-CH),7.08(dt,J=3.2,1.5Hz,2H,Ar-H),6.86(d,J=8.3 Hz,2H,Ar-H),6.81-6.76(m,4H,Ar-H),6.60(d,J=8.4Hz,2H,Ar-H),6.42(ddd,J=5.6,3.4,0.8Hz,4H,Ar-H), 2.50-2.28(m,6H,CH2),2.17(s,12H,CH3),2.16(s,12H,CH3),2.14-2.04(m,2H,CH2),1.42-1.19(m,8H,CH2). 31 P{ 1 H}NMR(162MHz,C6D6)δ107.8(s)ppm.

[0123] Preparation Example 3: Ligand 3

[0124]

[0125] 25g (155.3mmol) 1H-indole-6-boric acid (1a), 2.7g (3.1mmol) precatalyst and 500mL THF are loaded into 3-neck 2L round-bottomed flasks. The mixture is stirred at room temperature. After 5 minutes, 41.2g (170.8mmol) 1-bromo-3,5-di-tert-butylbenzene (2c) is added to the solution, and then about 600mL potassium phosphate aqueous solution (99g, 600mL H2O in 466mmol) is added. Then the reaction mixture is stirred at room temperature overnight. The next morning, aliquots are removed and analyzed by UP-LC, showing the complete consumption of starting material. Ether (400mL) is added and then the mixture is transferred to a separating funnel. The organic layer is separated, and the aqueous layer is further washed with 200mL of ether (2X). Combine organic layers, and anhydrous MgSO4 is dried on. Solvent is removed under reduced pressure to obtain a light brown solid. Next, it is dissolved in ether and treated with activated carbon to decolorize. The product was passed through Celite TM Filter through a pad of Celite® and concentrate to give a light brown solid. The solid is purified by trituration as described below.

[0126] Grinding process: hexane (300mL, about 10ml / g crude material) is added to the crude material. The mixture is heated in a water bath (55°C) for 15 minutes to dissolve non-polar impurities, and the mixture is quickly filtered with a glass filter to collect the pure product. After the first grinding, 23.0g of pure product 3c is isolated as a white powder. The filtrate from the first grinding is concentrated on a rotary evaporator to leave a solid residue, which is purified by using hexane: ethyl acetate as an eluent silica gel column chromatography to obtain a second batch of products (3c, 7.5g) as a white solid. 1 H NMR(400MHz,Chloroform-d)δ8.18(s,1H),7.72(d,J=8.2Hz,1H),7.62(dt,J=1.7,0.8Hz,1H),7.51(d,J=1.8Hz,2H),7 .45(t,J=1.8Hz,1H),7.42(dd,J=8.2,1.5Hz,1H),7.25–7.21(m,1H),6.60(ddd,J=3.1,2.0,1.0Hz,1H),1.43(s,18H). 13C NMR (101MHz, Chloroform-d) δ150.95,141.70,136.91,136.35,127.02,124.59,122.00,120.79,120.72,120.19,109.73,102.54,34.97,31.57.

[0127]

[0128] A toluene (50mL) solution of triethylamine (34mL, 245.5mmol) was loaded into a 110mL glass jar and cooled in a glove box refrigerator. PCl3 (3.6mL, 41.1mmol) loaded into a 1L round-bottom flask together with 50mL toluene was placed in a glove box refrigerator at the same time. After one hour, both solutions were taken out of the refrigerator and the triethylamine solution was slowly added to the PCl3 solution. Additional 175mL of cooling toluene was added to the flask to keep the concentration at about 0.2M (relative to PCl3). 6-(3,5-di-tert-butyl)-1H-indole (3c, 25.0g, 81.8mmol) was weighed into a 110mL glass jar and slowly added to cold PCl3 / NEt3 solution in batches under vigorous stirring over a period of 0.5 hour to 1 hour. White precipitate began to form during the addition. The reaction mixture was warmed to room temperature and stirred for another 12 hours. By 31 The progress of the reaction was monitored by P NMR. The next day, an aliquot of the reaction mixture was removed, filtered, and 31 P NMR spectroscopy analysis. NMR showed the formation of the desired monochlorophosphoramide (4c, δ 108.17 ppm) as the major product along with a small amount of tri(indolyl)phosphine (δ 70.95 ppm). The crude reaction mixture was passed through Celite TM The filtrate was transferred to a 1 L flask and concentrated to a volume of 200 mL using a glove box vacuum pump (vacuum trap cooled with liquid nitrogen). The crude reaction mixture was sampled for 31 P NMR and then used directly in the next step.

[0129]

[0130] In a N2-purged glove box, bis[6-(3,5-di-tert-butylphenyl)-1H-indolyl]chlorophosphine (4c, 27.75 g, 41.1 mmol) and toluene (200 mL) were charged into a 1 L round-bottom flask and stored in a glove box freezer for one hour (-35 ° C). A toluene (50 mL) solution of 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 5.5 g, 18.7 mmol) was slowly added. Triethylamine (15.5 mL, 112 mmol) was then added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate; the reaction mixture then became turbid and yellow. The mixture was stirred at room temperature. After one hour, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR analysis showed complete conversion to the bis(phosphoramidite) product (ligand L3, δ 112.73 ppm) as well as some cyclic phosphoramidite (<2%, δ 130.53 ppm) and tri(indolyl)phosphine (<6%, δ 70.96 ppm) byproducts. The reaction mixture was taken out of the glove box and purified by Celite TM The crude material was separated into two batches (about 10 g to 12 g of crude material per batch) for silica gel chromatography. Hexane-DCM was used as eluent and two 330 g columns were used to purify the material. After purifying two batches, the total isolated product was about 20 g of white powder material with a yield of 71% and a purity of 98%. 1 H NMR(400MHz,Chloroform-d)δ7.54(dd,J=15.6,8.3Hz,2H),7.38–7.27(m,6H),7.20(d,J=1.8Hz,2 H),7.15(d,J=1.8Hz,2H),7.13–7.08(m,1H),6.98–6.91(m,1H),6.74(d,J=1.5Hz,2H),6.56(d,J= 3.4Hz,1H),6.42(d,J=3.4Hz,1H),2.49(dt,J=16.3,6.3Hz,1H),2.28(dt,J=16.2,6.3Hz,1H),2.1 5(dt,J=17.2,6.4Hz,1H),2.03(dt,J=17.4,6.2Hz,1H),1.33(d,J=8.0Hz,39H),1.28–1.14(m,1H). 31 P{ 1 H}NMR (162MHz, Chloroform-d) δ 110.59ppm.

[0131] Preparation Example 4: Ligand 4

[0132]

[0133] In 3 neck 250mL round bottom flasks, 2.0g (12.4mmol) 1H-indole-6-boric acid (1a), 210mg (0.25mmol) precatalyst and 80mL THF are loaded.The mixture is stirred at room temperature for 5 minutes.After 5 minutes, 4.2g (13.7mmol) 1-bromo-3,5-diphenylbenzene (2d) is added to the solution, and then about 50mL potassium phosphate aqueous solution [25mL H2O 7.9g (38mmol)] is added.Then the reaction mixture is stirred at room temperature overnight.The next day, the reaction is monitored by LC-MS.Once all starting materials are consumed, ether (80mL) is added, and the reaction mixture is transferred to a separating funnel.The organic layer is separated, and the aqueous layer is further washed with 80mL ether (2X).Merge organic layer, and MgSO4 and activated carbon are dried. The solvent was removed under reduced pressure to afford a light brown solid which was purified by silica gel chromatography (5% to 15% ethyl acetate in hexanes) to afford 1.98 g (46% yield) of the product. 1 H NMR(400MHz,Chloroform-dδ8.22(s,1H),7.87(d,J=1.7Hz,1H),7.78(m,2H),7.77–7 .69(m,6H),7.56–7.45(m,5H),7.45–7.36(m,2H),7.26(m,1H),6.62(t,J=2.6Hz,1H). 13 C NMR(101MHz,Chloroform-d)δ143.38,142.24,141.34,136.37,135.42,128.8 1,127.45,127.37,125.41,124.94,124.57,121.01,119.91,109.73,102.63.

[0134]

[0135] In a N2 purged glove box, phosphorus trichloride (0.4mL, 4.6mmol) and triethylamine (6.9mL) were added to 50mL toluene in a 110mL glass jar. The solution was placed in a glove box freezer (-35°C) for 1 hour to cool. 6-(3,5-di-tert-butyl)-1H-indole (3d, 3.0g, 9.8mmol) was weighed into a 50mL glass jar and dissolved in 25mL toluene. The PCl3 / NEt3 solution was removed from the freezer and the indole solution was added dropwise to the cold PCl3 / NEt3 solution under stirring (via an additional funnel). A large amount of white precipitate was formed during the addition. The reaction mixture was warmed to room temperature and stirred overnight. The next day, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis. The NMR spectrum showed the formation of the desired monochlorophosphoramide as the major product (δ 105.61 ppm) and the dichloro compound as the minor product (δ 145.42 ppm). After 12 hours, 0.2 equivalents of the indole compound were slowly added, and one hour later, the mixture was stirred for 1 hour. 31 The reaction was further analyzed by P NMR spectroscopy, indicating complete conversion, mainly to the desired monochlorophosphoramide (δ 105.61 ppm) and about 4% to 5% of the dichloro compound (δ 145.42 ppm) as a minor product. The crude mixture was filtered through a Celite plug to remove inorganic salts, and the filtrate was further evaporated using a glove box vacuum pump (keeping liquid nitrogen in the trap), leaving 3.11 g of the desired monochlorophosphoramide as a light yellow powder (>90% yield), which was then used directly in the next step.

[0136]

[0137] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 11, 1.2 g, 4.1 mmol) and bis[6-(3,5-diphenyl-phenyl)-1H-indolyl] chlorophosphine (4d, 7.25 g, 8.6 mmol) were weighed into a 220 mL glass jar and dissolved in 80 mL toluene to produce a red-yellow solution and kept in a refrigerator for one hour (-35 ° C). Triethylamine (3.4 mL, 24.5 mmol) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature and slowly warmed to 50 ° C overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and washed with water by evaporation. 31P NMR spectroscopy analysis; Show that it is completely converted into product (δ 111.01ppm) and some cyclic phosphoramidite products (δ 128.22ppm). Two-step purification is required to remove all accompanying by-products. In the first step, 330g gold silica gel column (5% to 30% dichloromethane in hexane solution) is used to purify the double product and the remaining by-product. In the second step, 160g neutral alumina column is used to further purify the double phosphoramidite product from the indole by-product (5% to 20% dichloromethane in hexane solution). After column purification, 1.9g pure double phosphoramidite product (ligand L4) is obtained, and the yield is 24%. 1 HNMR(400MHz,Chloroform-d)δ7.70(m,2H),7.65–7.55(m,9H),7.51–7.41( m,14H),7.37(m,6H),7.34–7.26(m,1H),7.06(m,1H),6.99–6.93(m,1H),6.7 7(d,J=8.3Hz,1H),6.66(d,J=8.4Hz,1H),6.52(d,J=3.4Hz,1H),6.37(d,J=3 .4Hz,1H),2.47(m,1H),2.22(m,2H),2.03(m,1H),1.40(m,3H),1.26(m,3H). 31 P{ 1 H}NMR(162MHz,Chloroform-d)δ110.53ppm.

[0138] Preparation Example 5: Ligand 5

[0139]

[0140] Into 3 neck 2L round bottom flasks, 2g (12.4mmol) 1H-indole-6-boric acid (1a), 0.2g (0.25mmol) precatalyst and 80mL THF are loaded.The mixture is stirred at room temperature.After 5 minutes, 3.0g (13.7mmol) 1-bromo-3,5-dimethoxybenzene (2e) is added to the solution, and then about 50mL potassium phosphate aqueous solution (25mL H2O in 7.9g, 38mmol) is added.Then the reaction mixture is stirred at room temperature overnight.The next morning, aliquots are removed and analyzed by LC-MS, showing the complete consumption of starting material.Add ether (80mL) and then the mixture is transferred to a separating funnel.The organic layer is separated, and the aqueous layer is further washed with 50mL ether (2X).Merge organic layer, and anhydrous MgSO4 is upper dried.Remove solvent under reduced pressure to obtain a light brown solid. The solid was purified by silica gel column chromatography using hexane:ethyl acetate as eluent to obtain 2.1 g of the product (3e, 66% yield). 1 H NMR(400MHz, CDCl3)δ8.21(s,1H),7.70(d,J=8.2Hz,1H),7.63–7.56(m,1H),7.39(dd,J=8.2,1.6Hz, 1H),7.24–7.18(m,1H),6.82(d,J=2.2Hz,2H),6.73–6.53(m,1H),6.48(t,J=2.3Hz,1H),3.87(s,6H). 13 C NMR (101MHz, CDCl3) δ160.97,144.61,136.23,135.49,127.46,124.92,120.80,119.73,109.59,105.71,102.55,98.73,55.39.

[0141]

[0142] In a N2 purged glove box, phosphorus trichloride (0.3mL, 3.2mmol) and triethylamine (2.7mL) were added to 20mL toluene in a 110mL glass jar. The solution was placed in a glove box freezer (-35°C) for 1 hour to cool. 6-(3,5-dimethoxyphenyl)-1H-indole (3e, 1.65g, 6.5mmol) was weighed into a 50mL glass jar and dissolved in 10mL toluene. The PCl3 / NEt3 solution was removed from the freezer and the indole solution was added dropwise to the cold PCl3 / NEt3 solution under stirring (via an additional funnel). A large amount of white precipitate was formed during the addition. The reaction mixture was warmed to room temperature and stirred overnight. The next day, an aliquot of the reaction mixture was removed, filtered, and filtered through31 P NMR spectroscopy analysis.NMR spectrum shows the expected monochlorophosphoramide (d 102.64ppm) formed as the main product.Through Celite plug filter crude mixture to remove inorganic salts, and use glove box vacuum pump to further evaporate the filtrate (liquid nitrogen is kept in the trap) to obtain the expected monochlorophosphoramide as a light yellow powder (> 90% yield).This compound is directly used in the next step without further purification.

[0143]

[0144] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 0.44g, 1.48mmol) was dissolved in 5mL toluene and slowly added to a cooling solution of bis[6-(3,5-dimethoxyphenyl)-1H-indolyl]chlorophosphine (4e, 3mmol in 5mL toluene) in a 110mL glass jar. Under stirring, triethylamine (2.5mL, 17mmol) was added dropwise to the solution, resulting in the immediate formation of a yellow precipitate. The reaction mixture was stirred at room temperature and slowly warmed to room temperature overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and the reaction mixture was purified by HPLC. 31 P NMR spectroscopy analysis; Completely converted into product bisphosphoramidite (δ 109.00ppm) and some cyclic phosphoramidites (δ 129.16ppm). Make the reaction mixture pass through Celite pad, wash with toluene, and the filtrate is concentrated to a reddish oil. Silica gel purification is required to remove all accompanying by-products. 330g gold silica gel column (50% to 100% hexane solution of dichloromethane) is used to purify the desired product and remaining by-products. After column purification, 0.5g pure bisphosphoramidite product (ligand L5) is obtained, and the yield is 25%.

[0145] 1H NMR(400MHz,Chloroform-d)δ7.52(d,J=8.3Hz,1H),7.47(d,J=8.2Hz,1H),7.42(d,J=6.9Hz,2H),7.2 9(ddd,J=8.2,4.6,1.5Hz,2H),7.08–7.06(m,1H),7.03–6.94(m,1H),6.81–6.74(m,2H),6.54(dd,J=10 .4,2.2Hz,4H),6.50(d,J=3.5Hz,1H),6.41–6.40(m,2H),6.38(d,J=3.5Hz,1H),3.76(s,6H),3.75(s, 6H), 2.57 (dt, J=16.4, 6.3Hz, 1H), 2.39 (dt, J=16.4, 6.1Hz, 1H), 2.26–1.99 (m, 2H), 1.65–1.19 (m, 4H). 31 P{ 1 H}NMR(162MHz,Chloroform-d)δ107.72ppm.

[0146] Preparation Example 6: Ligand 6

[0147]

[0148] 4g (24.849mmol) of 1H-indole-6-boric acid (1a), 420mg (0.497mmol) of pre-catalyst and 160mL of THF were loaded into 3-neck 250mL round-bottomed flasks. The mixture was stirred at room temperature for 5 minutes. After 5 minutes, 5.825 (27.334mmol) of 1-bromo-4-tert-butylbenzene (2f) were added to the solution, and then about 50mL of potassium phosphate tribasic aqueous solution (25mLH2O in 16g, 38mmol) was added. The reaction mixture was then stirred at room temperature overnight. The next day, the reaction was monitored by LC-MS. Ether (80mL) was added to the reaction mixture, and then the mixture was transferred to a separating funnel. The organic layer was separated, and the aqueous layer was further washed with 80mL of ether (2X). The organic layers were combined, and MgSO4 was dried on the upper side. The solvent was removed under reduced pressure to obtain a light brown solid. The solid was purified by silica gel chromatography to obtain 4.2g (65% yield) product (3f). 1H NMR(400MHz,Chloroform-d)δ8.12(s,1H),7.71(d,J=8.1Hz,1H),7.66–7.57(m,3H), 7.50(d,J=7.9Hz,2H),7.42(d,J=8.2Hz,1H),7.21(s,1H),6.59(s,1H),1.41(s,9H). 13 C NMR (101MHz, CDCl3) δ149.53,139.36,136.38,135.42,127.02,126.97,125.63,124.63,120.80,119.75,109.32,102.49,34.47,31.40.

[0149]

[0150] In a N2 purged glove box, phosphorus trichloride (0.52mL, 5.9mmol) and triethylamine (4.9mL) were added to 70mL toluene in a 110mL glass jar. The solution was placed in a glove box freezer (-35°C) for 1 hour to cool. 6-(4-tert-butylphenyl)-1H-indole (3f, 4.1g, 11.87mmol) was weighed into a 50mL glass jar and dissolved in 10mL toluene. PCl3 / NEt3 solution was removed from the freezer and indole solution was added dropwise to cold PCl3 / NEt3 solution under stirring (via an additional funnel). A large amount of white precipitates were formed during the addition. The reaction mixture was warmed to room temperature and stirred overnight. The next day, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis.NMR spectrum shows the formation of the desired monochlorophosphoramide (δ 100.99ppm) as the main product.Through Celite plug filter crude mixture to remove inorganic salts, and use glove box vacuum pump to further evaporate the filtrate (liquid nitrogen is maintained in the trap) to obtain required monochlorophosphoramide as a light brown powder.This compound is directly used in the next step without further purification.

[0151]

[0152] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 0.5 g, 1.7 mmol) and bis[6-(4-tert-butylphenyl)-1H-indolyl]chlorophosphine (1.3 g, 2.335 mmol) were weighed into a 110 mL glass jar and dissolved in 34 mL toluene to produce a red-yellow solution and kept in a refrigerator for one hour (-35 ° C). Triethylamine (1.4 mL) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature and slowly warmed to 50 ° C overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis. 31 P NMR showed complete conversion to the desired bisphosphoramidite product with some cyclic phosphoramidite and triphosphoramidite products.The solid was purified by silica gel chromatography to afford 240 mg (11% yield) of the product (ligand L6). 1 HNMR (400MHz, CDCl3) δ7.70–7.45(m,6H),7.44–7.32(m,8H),7.10–6.99(m,2H),6.77–6.68(m,2H),6.48(d,J=3.5Hz,1H),6.41( d,J=3.4Hz,1H),2.55(dt,J=16.7,6.2Hz,1H),2.42–2.31(m,1H),2.29–2.16(m,1H),2.07(dt,J=17.5,6.3Hz,1H),1.34(m,22H). 31 P{ 1 H}NMR(162MHz,Chloroform-d)δ104.97ppm.

[0153] Preparation Example 7: Ligand 7

[0154]

[0155] 2g (12.4mmol) 1H-indole-6-boric acid (1a), 0.2g (0.25mmol) precatalyst and 80mL THF were loaded into 3-neck 250mL round-bottom flasks. The mixture was stirred at room temperature for 5 minutes. After 5 minutes, 2.5g (13.7mmol) 4-bromoanisole (2g) was added to the solution, followed by 25mL H The potassium phosphate aqueous solution (7.9g, 38mmol) of about 50mL in O. The reaction mixture was then stirred at room temperature overnight. The next day, the reaction was monitored by LC-MS. Ether (80mL) was added to the reaction mixture, and the mixture was then transferred to a separating funnel. The organic layer was separated, and the aqueous layer was further washed with 80mL of ether (2X). The organic layers were combined, and dried on MgSO and activated carbon. The solvent was removed under reduced pressure to obtain a light brown solid. The solid was purified by silica gel chromatography to obtain 2.0g (70%) product (3g). 1 H NMR(400MHz,Chloroform-d)δ8.15(s,1H),7.69(d,J=8.2Hz,1H),7.63–7.55(m,2H),7.55–7.51(m,1H),7.36 (dd,J=8.2,1.6Hz,1H),7.24–7.18(m,1H),7.04–6.96(m,2H),6.58(ddd,J=3.2,2.1,1.0Hz,1H),3.87(s,3H). 13 C NMR (101MHz, Chloroform-d) δ158.69,136.43,135.26,134.93,128.32,126.79,124.54,120.82,119.57,114.16,109.04,102.51,55.35.

[0156]

[0157] In a N2 purged glove box, phosphorus trichloride (0.3mL, 3.2mmol) and triethylamine (2.7mL) were added to 20mL toluene in a 110mL glass jar. The solution was placed in a glove box freezer (-35°C) for 1 hour to cool. 6-(4-methoxyphenyl)-1H-indole (3g, 1.45g, 6.5mmol) was weighed into a 50mL glass jar and dissolved in 10mL toluene. PCl3 / NEt3 solution was removed from the freezer and indole solution was added dropwise to cold PCl3 / NEt3 solution under stirring (via an additional funnel). A large amount of white precipitates were formed during the addition. The reaction mixture was warmed to room temperature and stirred overnight. The next day, an aliquot of the reaction mixture was removed, filtered, and filtered through 31P NMR spectroscopy analysis. NMR spectrum shows the formation of the required monochlorophosphoramide (d 103.29ppm) as the main product. The crude mixture is filtered through a Celite plug to remove inorganic salts, and the filtrate is further evaporated using a glove box vacuum pump (liquid nitrogen is kept in the trap), leaving 3.1g of required monochlorophosphoramide as a light yellow powder (>90% yield). The compound is directly used in the next step without further purification.

[0158]

[0159] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 0.4 g, 1.4 mmol) and bis[6-(4-methoxyphenyl)-1H-indolyl]chlorophosphine (4 g, 1.5 g, 2.9 mmol) were weighed into a 110 mL glass jar and dissolved in 10 mL toluene to produce a red-yellow solution and kept in a freezer for one hour (-35 ° C). Triethylamine (1.2 mL) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature and slowly warmed to 50 ° C overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and washed with water by filtration. 31 P NMR spectroscopy analysis; Completely converted into bisphosphoramidite product (δ 104.37ppm). Two-step purification is required to remove all accompanying by-products. In the first step, 330g gold silica gel column (5% to 20% dichloromethane in hexane solution) is used to purify the double product and the remaining by-product. In the second step, 160g neutral alumina column is used to further purify the bisphosphoramidite product from the indole by-product (5% to 20% dichloromethane in hexane solution). After column purification, 0.6g pure bisphosphoramidite product (ligand L7) is obtained, and the yield is 35%. 1H NMR(400MHz,Chloroform-d)δ7.62(d,J=6.4Hz,4H),7.52(d,J=8.2Hz,2H),7.47(d,J=8.2Hz,2H),7.39–7.26(m, 12H),7.19–7.13(m,2H),7.06(dt,J=3.2,1.5Hz,2H),6.85–6.74(m,10H),6.71(d,J=8.4Hz,2H),6.48(dd,J=3.4 ,0.8Hz,2H),6.42–6.36(m,2H),3.78(s,6H),3.77(s,6H),2.55(dt,J=16.7,6.3Hz,2H),2.35(dt,J=16.6,6.1Hz ,2H),2.22(dt,J=17.8,6.4Hz,2H),2.08(dt,J=17.5,6.2Hz,2H),1.60–1.40(m,4H),1.34(tq,J=8.7,2.8Hz,4H). 31 P{ 1 H}NMR(162MHz,Chloroform-d)δ104.37ppm.

[0160] Preparation Example 8: Ligand 8

[0161]

[0162] Into a three-necked 2L round-bottomed flask, one equivalent of 3,5-di-tert-butylphenylboronic acid (1b), 0.02 equivalent of pre-catalyst were loaded, and then THF was added to make the final concentration about 0.3M. The mixture was stirred at room temperature for 5 minutes. Afterwards, 1.1 equivalents of bromo-indole (2h) were added to the solution, followed by 1M potassium phosphate tripotassium aqueous solution (3 equivalents of K3PO4). The reaction mixture was then stirred at room temperature overnight. The next morning, aliquots were removed and analyzed by LC-MS. Once the reaction showed that the starting material was completely consumed, ether was added, and the mixture was then transferred to a separatory funnel. The organic layer was separated, and the aqueous layer was further washed with ether. The organic layers were combined and dried on anhydrous MgSO4. The solvent was removed under reduced pressure to obtain a crude product. Next, it was dissolved in ether and treated with activated carbon to decolorize. The product was passed through Celite TM The pad of Celite was filtered and concentrated, then purified by silica gel column chromatography (20% ethyl acetate in hexanes) to isolate the pure material (3 h, 69% yield). 1HNMR (400MHz, CDCl3) δ8.17 (s, 1H), 7.91–7.85 (m, 1H), 7.51 (d, J = 1.8Hz, 2H), 7.49–7.4 5(m,2H),7.43(t,J=1.8Hz,1H),7.24(t,J=2.8Hz,1H),6.67–6.60(m,1H),1.42(s,18H). 13 CNMR (101MHz, CDCl3) δ150.87,141.89,135.18,134.70,128.33,124.72,122.29,122.02,120.49,119.38,111.04,102.95,34.96,31.57.

[0163]

[0164] In a nitrogen purged glove box, a toluene solution of triethylamine (6 equivalents) was added to a 110 mL glass jar and placed in a glove box refrigerator. A toluene solution of PCl3 (1 equivalent) was added to a 110 mL glass jar and placed in a glove box refrigerator at the same time. After one hour, both solutions were taken out of the refrigerator and the triethylamine solution was slowly added to the PCl3 solution. An additional amount of toluene was added to the flask to keep the final concentration at about 0.2 M (relative to PCl3). Substituted indole 3h (2 equivalents) was weighed into a 110 mL glass jar, dissolved in a minimum amount of toluene and slowly added to cold PCl3 / NEt3 solution over a period of 15 to 30 minutes under vigorous stirring. A white precipitate began to form during the addition. The reaction mixture was warmed to room temperature and stirred for another 12 hours. By 31 The progress of the reaction was monitored by P NMR. The next day, an aliquot of the reaction mixture was removed, filtered, and 31 P NMR analysis was performed to confirm the formation of the desired bis(indolyl)chlorophosphine 4h as the major product. The crude reaction mixture was passed through Celite TM The filtrate was transferred to a 220 mL glass jar and concentrated to approximately 1 / 4 of its original volume using a glove box vacuum pump (vacuum trap cooled with liquid nitrogen). The crude reaction mixture was sampled for 31 P NMR and used directly in the next step.

[0165]

[0166] In a N2-purged glove box, a toluene solution of bis(indolyl)chlorophosphine 4h (2.5 eq) was charged to a 110 mL glass jar and stored in a glove box refrigerator for one hour (-35°C). 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 1 eq) was dissolved in toluene in a vial and slowly added to the bis(indolyl)chlorophosphine solution at -35°C. Additional amounts of toluene were added to the glass jar to maintain a total concentration of approximately 0.15M to 0.2M. Triethylamine (4 eq) was then added dropwise to the solution at -35°C with stirring and slowly warmed to room temperature, resulting in the immediate formation of a white precipitate; the reaction mixture then became cloudy and yellow. The mixture was stirred at room temperature for one hour, then an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR analysis. Once the reaction showed complete conversion to the bisphosphoramidite product, the reaction mixture was taken out of the glove box and filtered through a Celite TM The filtrate was evaporated on a rotary evaporator to remove all inorganic salts. The volatiles were removed from the filtrate, leaving a light yellow oil. The crude material was further purified by silica gel column chromatography (20% dichloromethane in hexanes) to isolate the pure bisphosphoramidite ligand L8 (22% yield and 80% purity). 1 H NMR(400MHz, CDCl3)δ7.78–7.73(m,3H),7.56(dd,J=5.7,3.3Hz,1H),7.51–7.4 0(m,6H),7.39–7.28(m,2H),7.13–7.04(m,2H),6.91(d,J=8.5Hz,1H),6.80(d, J=8.4Hz,1H),6.61(td,J=4.2,3.4,1.9Hz,1H),6.57(dd,J=3.4,0.9Hz,1H),2. 78–2.51(m,2H),2.40–2.08(m,2H),1.72–1.52(m,3H),1.40(d,J=1.7Hz,37H).

[0167] 31 P{ 1 H}NMR (162MHz, CDCl3) δ106.70ppm.

[0168] Preparation Example 9: Ligand 9

[0169]

[0170] Into a three-necked 2L round-bottomed flask, one equivalent of 3,5-di-tert-butylphenylboronic acid (1b), 0.02 equivalent of pre-catalyst, and then THF was added to make the final concentration about 0.3M. The mixture was stirred at room temperature for 5 minutes. Afterwards, 1.1 equivalents of bromo-indole 2i were added to the solution, followed by 1M potassium phosphate tripotassium aqueous solution (3 equivalents of K3PO4). The reaction mixture was then stirred at room temperature overnight. The next morning, aliquots were removed and analyzed by LC-MS. Once the reaction showed that the starting material was completely consumed, ether was added, and the mixture was then transferred to a separatory funnel. The organic layer was separated, and the aqueous layer was further washed with ether. The organic layers were combined and dried on anhydrous MgSO4. The solvent was removed under reduced pressure to obtain a crude product. Next, it was dissolved in ether and treated with activated carbon to decolorize. The product was passed through Celite TM The pad of Celite was filtered and concentrated, then purified by silica gel column chromatography (20% ethyl acetate in hexanes) to isolate the pure material (3i, 73% yield). 1 HNMR (400MHz, CDCl3) δ8.23(s,1H),7.58(d,J=1.8Hz,2H),7.46(t,J=1.9Hz,1H),7.40(dt,J=7.9,1. 1Hz, 1H), 7.30 (t, J=7.6Hz, 1H), 7.27–7.25 (m, 2H), 6.75 (ddd, J=3.2, 2.1, 1.0Hz, 1H), 1.42 (s, 18H). 13 C NMR (101MHz, CDCl3) δ150.66,140.27,136.26,135.64,126.27,124.25,123.24,122.32,120.87,119.70,109.90,102.46,34.97,31.58.

[0171]

[0172] In a N2 purged glove box, a toluene solution of triethylamine (6 equivalents) was added to a 110 mL glass jar and placed in a glove box refrigerator. A toluene solution of PCl3 (1 equivalent) was added to a 110 mL glass jar and placed in a glove box refrigerator at the same time. After one hour, both solutions were taken out of the refrigerator and the triethylamine solution was slowly added to the PCl3 solution. An additional amount of toluene was added to the flask to keep the final concentration at about 0.2 M (relative to PCl3). The substituted indole 3i (2 equivalents) was weighed into a 110 mL glass jar, dissolved in a minimum amount of toluene and slowly added to cold PCl3 / NEt3 solution in a period of 15 to 30 minutes under vigorous stirring. A white precipitate began to form during the addition. The reaction mixture was warmed to room temperature and stirred for another 12 hours. By 31 The progress of the reaction was monitored by P NMR. The next day, an aliquot of the reaction mixture was removed, filtered, and 31 P NMR analysis was performed to confirm the formation of the desired bis(indolyl)chlorophosphine 4h as the major product. The crude reaction mixture was passed through Celite TM The filtrate was transferred to a 220 mL glass jar and concentrated to approximately 1 / 4 of its original volume using a glove box vacuum pump (vacuum trap cooled with liquid nitrogen). The crude reaction mixture was sampled for 31 P NMR and used directly in the next step.

[0173]

[0174] In a N2-purged glove box, a toluene solution of bis(indolyl)chlorophosphine 4i (2.5 eq.) was charged to a 110 mL glass jar and stored in a glove box refrigerator for one hour (-35°C). 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 1 eq.) was dissolved in toluene in a vial and slowly added to the bis(indolyl)chlorophosphine solution at -35°C. Additional amounts of toluene were added to the glass jar to maintain a total concentration of approximately 0.15M to 0.2M. Triethylamine (4 eq.) was then added dropwise to the solution at -35°C with stirring and slowly warmed to room temperature, resulting in the immediate formation of a white precipitate; the reaction mixture then became cloudy and yellow. The mixture was stirred at room temperature for one hour, then an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR analysis. Once the reaction showed complete conversion to the bisphosphoramidite product, the reaction mixture was taken out of the glove box and filtered through a Celite TMPellet with Celite® to remove all inorganic salts. The filtrate volatiles were removed on a rotary evaporator to leave a light yellow oil. The crude material was further purified by silica gel column chromatography (20% dichloromethane in hexanes) to isolate pure bisphosphoramidite ligand L9 (50% yield). 1 H NMR (400MHz, CDCl3) δ7.54–7.43(m,8H),7.29–7.23(m,2H),7.20–7.16(m,3H),7.16–7.08(m,1H),6.90–6.79(m,2H),6.72(t ,J=3.2Hz,2H),2.70–2.63(m,1H),2.58–2.51(m,1H),2.40–2.31(m,1H),2.21–2.14(m,1H),1.71–1.49(m,3H),1.42(m,37H). 31 P{ 1 H}NMR (162MHz, CDCl3) δ104.70ppm.

[0175] Preparation Example 10: Ligand 10

[0176]

[0177] In a N2 purged glove box, 4,4',5,5',6,6'-hexamethyl-[1,1'-biphenyl]-2,2'-diol (5b, 1.0 g, 3.7 mmol) and bis[6-(3,5-di-tert-butylphenyl)-1H-indolyl]chlorophosphine (4c, 6.2 g, 8.13 mmol) were weighed into a 220 mL glass jar and dissolved in 75 mL toluene to produce a reddish yellow solution and kept in a freezer for one hour (-35 ° C). Triethylamine (1.6 mL, 11.1 mmol) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature and slowly warmed to 50 ° C overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and washed with water by evaporation. 31 P NMR analysis. Two-step purification is required to remove all accompanying by-products. In the first step, 330g gold silica gel column (5% to 20% dichloromethane in hexane solution) is used to purify the double product and the remaining by-product. In the second step, 160g neutral alumina column is used to further purify the bisphosphoramidite product (5%-20% dichloromethane in hexane). After column purification, 1.2g pure bisphosphoramidite ligand L10 is obtained, and the yield is 28%. 1H NMR (400MHz, Chloroform-d) δ7.56 (dd, J=8.0, 2.8Hz, 4H), 7.40–7.29 (m, 12H), 7.21 (dt, J=6.0, 1.3Hz, 8H), 7.07 (dt, J= 11.6, 2.9Hz, 4H), 6.58 (s, 2H), 6.53–6.45 (m, 4H), 2.01 (s, 6H), 1.80 (s, 6H), 1.76 (s, 6H), 1.33 (dd, J = 3.4, 1.1Hz, 72H). 31 P{ 1 H}NMR(162MHz,Chloroform-d)δ109.41ppm.

[0178] Preparation Example 11: Ligand 11

[0179]

[0180] In a N2 purged glove box, 2,2',3,3'-tetrahydro-1,1'-spirobis[indene]-7,7'-diol (5c, 0.275 g, 1.2 mmol) was added to a cooled solution of bis[6-(3,5-di-tert-butylphenyl)-1H-indolyl]chlorophosphine (4c, 2.8 mmol) in toluene (10 mL) in a 110 mL glass jar. Triethylamine (0.7 mL, 4.8 mmol) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature and slowly warmed to room temperature overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis; The reaction was very clean, and only one main peak (δδ 105.28ppm) and some minor products were observed. The glass jar was taken out from the glove box, and the reaction mixture was passed through a celite pad. The filtrate was concentrated and loaded directly onto a 330g silica column using liquid injection. A silica gel column was required to remove all accompanying by-products. A 330g gold silica gel column (5% to 25% hexane solution of dichloromethane) was used to purify the double product and the remaining by-product. After column purification, 0.95g of pure bisphosphoramidite product ligand L11 was obtained in a yield of 51%. 1H NMR(400MHz,Chloroform-d)δ7.56(dd,J=10.6,8.1Hz,4H),7.47–7.40(m,4H),7.40–7.31(m,8H),7.24(d d,J=8.8,1.8Hz,8H),6.99(t,J=3.3Hz,2H),6.84(t,J=3.2Hz,2H),6.76(dd,J=8.1,7.3Hz,2H),6.68(d,J= 8.0Hz,2H),6.62(d,J=7.3Hz,2H),6.53(dd,J=3.4,0.9Hz,2H),6.47(dd,J=3.4,0.8Hz,2H),2.78(m,2H),2 .43(dd,J=16.0,8.6Hz,2H),2.08(dd,J=12.6,7.6Hz,2H),2.03–1.89(m,2H),1.36(s,36H),1.33(s,36H). 31 P{ 1 H}NMR (162MHz, Chloroform-d) δ 105.28ppm.

[0181] Preparation Example 12: Ligand 12

[0182]

[0183] In a N2 purged glove box, phosphorus trichloride (0.6mL, 7.0mmol) and triethylamine (3.0mL) were added to 20mL toluene in a 110mL glass jar. The solution was placed in a glove box freezer (-35°C) for 1 hour to cool. 6,7-fused-1H-indole (3l, 1.1g, 7.0mmol) was weighed into a 50mL glass jar and dissolved in 15mL toluene. The PCl3 / NEt3 solution was removed from the freezer and the indole solution was added dropwise to the cold PCl3 / NEt3 solution under stirring. The reaction mixture was warmed to room temperature and stirred for another 3 hours. After 3 hours, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis. The NMR spectrum showed the formation of the desired dichloroindolylphosphine 4l' (δ 147.30ppm) as the major product. The crude NMR was clean enough to proceed to the next step. The crude mixture was filtered through a Celite plug to remove inorganic salts, and the filtrate was further concentrated using a glove box vacuum pump (liquid nitrogen was kept in the trap) to a 10 mL solution.

[0184] Then, the dichloroindolylphosphine solution (41') was kept in a glove box freezer (-35°C) for 1 hour to cool. 1H-Indole (0.82g, 7.0mmol) was weighed into a 50mL glass jar and dissolved in 15mL toluene. The dichloroindolylphosphine solution was removed from the freezer and 3.0mL triethylamine was added to the solution. Then, indole solution was added dropwise to the reaction solution under stirring. The reaction mixture was warmed to room temperature and stirred for another 3 hours. After 3 hours, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis. The NMR spectrum showed the formation of the desired monochlorodiindolylphosphine 41 (δ 101.76ppm) as the main product. The crude NMR was clean enough to proceed to the next step. The crude mixture was filtered through a Celite plug to remove inorganic salts, and the filtrate was further concentrated using a glove box vacuum pump (liquid nitrogen was kept in the trap) to a 10mL solution.

[0185]

[0186] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2-naphthol (5a, 0.82g, 2.8mmol) was dissolved in 5mL toluene and placed in a 110mL glass jar. A toluene solution of bis[indolyl]phosphine chloride 4l (7.0mmol in 10mL) was slowly added to the binaphthol solution, and the reaction was kept in a refrigerator for one hour (-35°C). Triethylamine (2.3mL) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis; observed complete conversion to bisphosphoramidite (δ 101.68ppm) with some minor products. Silica gel column is required to remove all accompanying by-products. 330g gold silica gel column (20% to 50% dichloromethane in hexane) is used to purify the bis-product and the remaining by-products. After column purification, 0.9g of pure bisphosphoramidite product (ligand L12) is obtained with a yield of 36%. 1H NMR (400MHz, CDCl3) δ7.51(d,J=7.6Hz,1H),7.42(d,J=8.1Hz,1H),7.36(d,J=7.9Hz,1H),7.1 0(td,J=7.5,1.1Hz,1H),7.07–6.99(m,3H),6.89–6.78(m,2H),6.68(d,J=8.4Hz,1H),6.50(d, J=3.5Hz,1H),6.43(dd,J=3.5,0.8Hz,1H),3.20(dt,J=14.5,6.9Hz,1H),3.01-2.83(m,3H),2 .72–2.51(m,2H),2.33–2.21(m,1H),2.20–2.09(m,1H),2.07–1.99(m,2H),1.75–1.41(m,4H). 31 P{ 1 H}NMR(162MHz,C6D6)δ100.79(s)ppm.

[0187] Preparation Example 13: Ligand 13

[0188]

[0189] 2.0g 3,5-di-tert-butylboric acid (1c), 145mg pre-catalyst and 25mLTHF are loaded into 3 neck 250mL round-bottomed flasks.The mixture is stirred at room temperature for 5 minutes.After 5 minutes, 5ml THF solution of 1.97g 3-methyl-6-bromoindole (2m) is added in reaction flask, then about 40mL potassium phosphate aqueous solution (40mL H2O in 5.3g, 25mmol) is added.Then the reaction mixture is stirred at room temperature overnight.The next day, the reaction is monitored by LC-MS.Ether (40mL) is added to the reaction mixture, and then the mixture is transferred to a separating funnel.The organic layer is separated, and the aqueous layer is further washed with 40mL ether (2X).Merge organic layer, and MgSO4 upper drying.Remove solvent under reduced pressure to obtain light brown solid.By ISCO silica gel chromatography purified solid to obtain 1.54g (55% yield) product. 1 H NMR (400MHz, CDCl3) δ7.92 (s, 1H), 7.65 (d, J = 8.2Hz, 1H), 7.56 (s, 1H), 7.50 ( t,J=1.5Hz,2H),7.47–7.36(m,2H),7.00(s,1H),2.38(s,3H),1.42(s,18H). 13C NMR (101MHz, CDCl3) δ150.92,141.82,136.82,136.78,127.49,122.05,122.01,120.73,119.45,118.87,111.71,109.72,34.97,31.57,9.70.

[0190]

[0191] In a N2 purged glove box, phosphorus trichloride (0.6mL) and triethylamine (5.2mL) were added to 40mL toluene in a 110mL glass jar. The solution was placed in a glove box freezer (-35°C) for 1 hour to cool. 6-(3,5-di-tert-butyl)-3-methyl-1H-indole (3m, 4.0g) was weighed into a 40mL vial and dissolved in 20mL toluene. The indole solution was also cooled in a glove box freezer for 1 hour. Both solutions were removed from the freezer and the cold indole solution was added dropwise to the cold PCl3 / NEt3 solution under stirring (through an additional funnel). A large amount of white precipitate was formed during the addition. The reaction mixture was warmed to room temperature and stirred overnight at 60°C. The next day, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis. NMR showed the formation of the desired monochlorophosphoramide as the major product (δ 102.43 ppm), however it also showed the dichloro compound as a minor product (δ 143.52 ppm). After 12 hours, 0.2 equivalents of the indole compound were slowly added to the reaction mixture, and one hour later, the reaction mixture was stirred for 1 hour by 31 P NMR spectroscopy further analyzes the reaction. The reaction display is fully converted into the desired monochlorophosphoramide as the major product (δ 102.43ppm) and as about 4% to 5% dichloro product (δ 143.52ppm) of the minor product. The crude mixture is filtered through a Celite plug to remove inorganic salts, and the filtrate is further evaporated using a glove box vacuum pump (keeping a liquid nitrogen trap), and 4.4g of the required monochlorophosphoramide (4m) is separated as a pale yellow powder (>90% yield).

[0192]

[0193] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 0.7g) and bis[6-(3,5-di-tert-butylphenyl)-3-methyl-1H-indolyl] iodophosphine (4m, 3.8g) were weighed into a 110mL glass jar and dissolved in 46mL toluene to produce a red-yellow solution and kept in a refrigerator for one hour (-35°C). Triethylamine (2.0mL) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature and slowly warmed to 50°C overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 PNMR spectroscopy analysis. 31 P NMR shows complete conversion to product (δ 107.89ppm) and some monohydric alcohol and cyclic phosphoramidite products. Two-step purification is used to remove all indole by-products. In particular, the 1st column purifies the double product and the remaining by-product (silica gel column), and the 2nd column purifies the double product in the indole by-product (alumina column). NMR shows pure product (ligand L13, 1.2g), and the yield is 31% (>95% purity). 1 H NMR (400MHz, CDCl3) δ7.56–7.45(m,4H),7.41–7.34(m,4H),7.33–7.21(m,4H),6.88(d,J=8.4Hz,1H),6.84–6.75(m,2H) ,6.60(s,1H),2.68–2.51(m,1H),2.43–2.38(m,1H),2.28–2.17(m,4H),2.13–2.04(m,4H),1.50–1.29(d,J=6.7Hz,40H). 31 P{ 1 H}NMR(162MHz,C6D6)δ107.89(s)ppm.

[0194] Preparation Example 14: Comparative Ligand 2

[0195]

[0196] In an aqueous glove box, (tert-butyloxycarbonyl) borate 1c (1.35 g, 3.94 mmol), precatalyst (0.06 g, 0.07 mmol) and THF (25 mL) were loaded into a 110 mL wide-mouth bottle. The reaction mixture was then stirred for 5 minutes. After 5 minutes, 1-bromo-3,5-di-tert-butylmethylbenzene (2c, 1.00 g, 3.71 mmol) was added to the reaction mixture, and potassium phosphate aqueous solution (2.36 g, 11.14 mmol, in 20 mL water) was added to the reaction mixture. The reaction mixture was then stirred at room temperature overnight. The next day, an aliquot was removed, treated with ether and checked by mass spectrometry. The reaction was completed, stopped and taken out from the glove box. Ether (50 mL) was added to the reaction mixture, and then transferred to a separatory funnel. The aqueous layer was then washed with equal portions of ether (2X). The organic layers were then merged, dried over MgSO4 and filtered through a neutral alumina and an activated carbon plug. The filtrate was then concentrated to give 1.5 g, 99.5%, as a brown solid. Compound (3j') was analyzed by NMR and transferred to the deprotection step.

[0197] In an aqueous glove box, a 50 mL wide-mouth bottle was charged with tert-butyl 3-(3,5-di-tert-butylphenyl)-1H-indole-1-carboxylate (3j', 1.50 g, 3.70 mmol), THF (30 mL) and a stirring bar. 25 wt% sodium methoxide (2.4 g, 11.10 mmol) was added slowly to avoid large exotherms. The reactants were stirred at room temperature overnight. In the morning, water was added, the reactants were removed from the glove box and water (30 mL) was added. The mixture was stirred for 15 minutes and then transferred to a separatory funnel. The product was extracted 3 times with ether, and the combined organic layers were dried over MgSO4, filtered and concentrated. The crude material was then dissolved in dichloromethane and passed through a silica gel plug. The filtrate was concentrated to give 0.88 g of pure product 3j. Yield: 77.5% 1 H NMR(400MHz, CDCl3) δ8.16(s,1H),7.92(ddq,J=7.8,1.5,0.8Hz,1H),7.52(dd,J=1.9,0.8 Hz,2H),7.44–7.40(m,1H),7.40–7.34(m,2H),7.29–7.16(m,2H),1.40(d,J=0.8Hz,18H). 13 C NMR (101MHz, CDCl3) δ151.18,136.80,134.63,126.17,122.45,122.20,121.74,120.41,120.35,120.08,119.57,111.50,35.09,31.72.

[0198]

[0199] In a N2 purged glove box, phosphorus trichloride (0.19 g, 1.40 mmol) and triethylamine (0.57 g, 5.62 mmol) were added to 50 mL toluene in a 110 mL glass jar. The solution was placed in a glove box freezer (-35 ° C) for 1 hour to cool. Indole 3j (0.86 g, 2.81 mmol g) was weighed into a 20 mL vial and dissolved in 10 mL THF. The indole solution was also cooled in the glove box freezer for 1 hour. Both solutions were removed from the freezer and the cold indole solution was added dropwise to the cold PCl3 / NEt3 solution under stirring. A large amount of white precipitate was formed during the addition. The reaction mixture was stirred at 50 ° C for 24 hours. By 31 The reaction was monitored by 1H NMR. Once the reaction was complete, the reaction mixture was filtered through Celite to remove triethylammonium chloride, and the light yellow filtrate was evacuated to dryness. The resulting residue was taken up in hexane, filtered and concentrated to give 0.72 g of crude product 4j. This material was used directly in the next step without any further purification. 31 P{ 1 H}NMR(162MHz,C6D6)δ100.0(s)ppm.

[0200]

[0201] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 0.09 g, 0.29 mmol) and 1,1'-(chlorophosphine diyl)bis(3-(3,5-di-tert-butylphenyl)-1H-indole) (4j, 0.39 g, 0.58 mmol) were weighed into a 50 mL glass jar containing a Teflon coated stirring bar. Toluene (10 mL) was added to dissolve the mixture. A solution of triethylamine (0.12 g, 1.16 mmol) in toluene (5 mL) was added dropwise to the solution under stirring. The reaction mixture was stirred at room temperature overnight. An aliquot of the reaction mixture was removed, filtered, and purified by 31 P NMR spectral analysis. Spectrum display is partially converted into desired product (δ 104ppm).Add another 0.04g diol, reactant is stirred at room temperature for another 24 hours.Once all starting chlorides disappear, reaction mixture is filtered through Celite to remove triethylammonium chloride, and colorless filtrate is evacuated to dryness to obtain light brown solid.Alumina column is needed to remove all accompanying by-products.24g gold silica gel column is used to purify double product and remaining by-product.After column purification, 0.1g pure bisphosphoramidite product (ligand CL2) is obtained, and productive rate is 22%. 1H NMR (400MHz, CDCl3) δ7.78 (dd, J=14.6, 7.9Hz, 5H), 7.58 (d, J=8.2Hz, 2H), 7.55–7.46 (m, 2H), 7.41–7.38 (m, 14H), 7.24–7.11 (m ,5H),7.08–7.0(m,4H),6.67(d,J=8.3Hz,2H),6.54(d,J=8.4Hz,2H),2.48–2.22(m,6H),2.19–1.98(m,5H),1.51–1.19(m,77H). 31 P{ 1 H}NMR(162MHz,C6D6)δ104.4(s)ppm.

[0202] Preparation Example 15: Comparative Ligand 3

[0203]

[0204] In N2 purged glove box, 4.43g (12.87mmol) 1- (tert-butyloxycarbonyl) indole -3- boronic acid pinacol ester (1c), 0.21g (0.24mmol) precatalyst and 40mL THF were loaded into 110mL wide-mouth bottle. The mixture was stirred at room temperature for 5 minutes. After 5 minutes, 1.65mL (12.14mmol) 1- bromo-3,5- dimethylbenzene (2b) was added to the solution, followed by addition of about 30mL potassium phosphate tripotassium aqueous solution (30mL H2O in 7.75g (36.51mmol)). Then the reaction mixture was stirred at room temperature overnight. The next day, the reactant was taken out from the glove box. Ether (40mL) was added to the reaction mixture, and then the mixture was transferred to a separatory funnel. The organic layer was separated, and the aqueous layer was further washed with 40mL ether (2X). The organic layers were combined and dried on MgSO4 and activated carbon. The ether solution was then filtered through a plug of basic alumina and the solvent removed under reduced pressure to afford a white solid. Yield: 3.9 g of impure material; appeared to be a mixture of the desired compound (3k') and pinacol bromoborane. The crude material was used in the next step of the reaction without further purification. 1H NMR (400 MHz, CDCl3) δ8.20 (brd, J=8.0 Hz, 1H, indole-CH), 7.81 (d, J=0.5 Hz, 1H, indole-CH), 7.68 (s, 1H, p-aryl CH), 7.37-7.31 (m, 1H, indole-CH), 7.30-7.26 (m, 1H, indole-CH), 7.26-7.24 (overlapping singlet, 2H, o-aryl CH), 6.99 (s, indole-CH), 2.40-2.37 (overlapping singlet, 6H, aryl-CH3), 1.68 (s, 9H, C(CH3)3), 1.23 (s, 7H, pinacol-CH3) ppm.

[0205] In a fume hood, the crude material (3.9g) from the previous reaction is loaded into a 3-neck round-bottom flask equipped with a nitrogen inlet, a diaphragm and a stirring rod. The flask is placed under nitrogen, and 1.50g (35.7mmol) of sodium methoxide, 40mL of THF and 10mL of methanol are further loaded. The reaction mixture is stirred at room temperature overnight. The next day, 50mL of water is slowly added to the reaction mixture. The mixture is then transferred to a separating funnel. The aqueous layer is extracted 3 times with equal parts of ether (about 50mL). The organic layers are combined, dried over MgSO4, filtered, and the solvent is removed under reduced pressure. The separated material is a yellow / brown solid. Hexane is added to the product, and a water bath is used to heat the mixture until the solid dissolves. The hexane solution is cooled to room temperature, during which solids are precipitated. The white solid is separated by filtration, and washed with cold hexane. Product 3k is dried under vacuum to obtain 1.52g of material (6.87mmol, 56.6% yield). 1 H NMR (400 MHz, CDCl3) δ8.17 (br s, 1H, NH), 7.93 (ddd, J=7.9, 1.3, 0.7 Hz, 1H, indole-CH), 7.43-7.39 (m, 1H, aryl / indole-CH), 7.33 (d, J=2.5 Hz, aryl / indole-CH), 7.30-7.27 (m, 2H, o-aryl CH), 7.26-7.15 (m, 2H, aryl / indole-CH), 6.96-6.91 (m, 1H, indole-CH), 2.38 (overlapping singlet, 6H, aryl-CH3) ppm.

[0206]

[0207] In a N2 purged glove box, phosphorus trichloride (0.26mL, 3.0mmol) and triethylamine (2mL, 14mmol) were added to 60mL toluene in a 110mL glass jar. The solution was placed in a glove box freezer (-35°C) for 1 hour to cool. 3-(3,5-dimethylphenyl)-1H-indole 3k (1.34g, 6.04mmol) was weighed into a 20mL jar and dissolved in 10mL toluene. The indole solution was also cooled in a glove box freezer for 1 hour. Both solutions were removed from the freezer and the cold indole solution was added dropwise to the cold PCl3 / NEt3 solution under stirring. A large amount of white precipitate was formed during the addition. The reaction mixture was warmed to room temperature and stirred overnight. The next day, an aliquot of the reaction mixture was removed, filtered, and filtered through 31 P NMR spectroscopy analysis. The reaction mixture was filtered through Celite to remove triethylammonium chloride, and the light yellow filtrate was evacuated to dryness. The resulting white residue was triturated with 40 mL of hexane to give a white solid. The solid was dried under vacuum for 1 hour. Yield: 1.19 g (2.35 mmol, 77.7%) Note: By 31 P NMR found 87% purity. Material 4k was considered pure enough to move to the next step of the reaction. 31 P{ 1 H}NMR(162MHz,C6D6)δ103.2(s)ppm.

[0208]

[0209] In a N2 purged glove box, 5,5',6,6',7,7',8,8'-octahydro-1,1'-di-2-naphthol (5a, 0.32 g, 1.1 mmol) and bis(3-(3,5-dimethylphenyl)indolyl)chlorophosphine (4k, 1.10 g, 2.17 mmol) were weighed into a 110 mL glass jar and dissolved in 60 mL toluene to produce a yellow solution. Triethylamine (1 mL, 7 mmol) was added dropwise to the solution under stirring, resulting in the immediate formation of a white precipitate. The reaction mixture was stirred at room temperature overnight. The next morning, an aliquot of the reaction mixture was removed, filtered, and washed with water by HPLC. 31 P NMR spectroscopy analysis. The spectrum showed good conversion to the desired product CL3 (105 ppm) with a purity of about 82%. The reaction mixture was filtered through Celite to remove triethylammonium chloride, and the yellow filtrate was pumped to dryness. The filtrate was loaded directly onto a 330 g silica column using liquid injection. A silica gel column was required to remove all accompanying by-products. A 330 g gold silica gel column (5% to 25% dichloromethane in hexane) was used to purify the product (CL3) and remaining by-products; total yield: 47.3%. 1H NMR (400MHz, C6D6) δ7.93(dd,J=12.7,7.9Hz,4H,Ar-H),7.77(d,J=8.1Hz,2H,Ar-H),7.64(d,J=8.2Hz,2H,A r-H),7.51(s,2H,Ar-H),7.44(s,2H,Ar-H),7.26-7.19(m,8H,Ar-H),7.14-7.02(m,6H,Ar-H),7.02-6.94(m, 2H, Ar-H), 6.84 (d, J=8.3Hz, 2H, Ar-H), 6.80 (d, J=8.6Hz, 4H, Ar-H), 6.59 (d, J=8.4Hz, 2H, Ar-H), 2.53 (dt, J= 17.4,5.7Hz,2H,CH2),2.40-2.19(m,6H,CH2),2.18(s,12H,CH3),2.14(s,12H,CH3),1.44-1.28(m,8H,CH2). 31 P{ 1 H}NMR(162MHz,C6D6)δ106.1(s)ppm.

[0210] Examples 1-13 and Comparative Examples 1-3 :

[0211] In the following Examples 1-13 and Comparative Examples 1-3, by 1 H NMR was used to measure the reaction conversion, selectivity and regioselectivity (N / I ratio). The product structure and composition were also determined by the C6D6 13 C NMR support.

[0212] pass 1 H and 13 C NMR analysis of the reaction mixture. Neat substrate hydroformylation involves catalyst activation during the initial reaction period or catalyst pre-activation in toluene prior to hydroformylation, followed by transfer of the activated catalyst to the specific substrate used. In addition to straight-chain aldehydes (i.e., n-butyraldehyde) as the main product, hydroformylation produces branched-chain aldehydes (i.e., isobutyraldehyde) as by-products, which are detected and analyzed by NMR.

[0213] Unless otherwise indicated, the examples and comparative experiments were conducted in a 90 mL flow-through Fisher Porter reactor immersed in an oil bath to establish a reaction temperature of 90°C. The reactor was also equipped with a mass flow meter for precise control of gas flow; reactor pressure was established and maintained by a back pressure regulator. The reactor offgas was analyzed by online GC to determine the molar composition. Mixing in the flow-through reactor was affected by a continuous gas flow through a distributor at the bottom of the reactor. The reactor design is described in detail in US 5,731,472, the teachings of which are incorporated herein by reference. The reaction rate is expressed as the number of moles of aldehyde produced per volume of catalyst solution per unit time (mole / L-hour); this value is additionally divided by the propylene partial pressure to help suppress the effects of small and inevitable fluctuations in the propylene feed rate (rate / olefin). Product selectivity is expressed as the ratio (N:I) of linear (normal) aldehydes to branched (iso) aldehydes.

[0214] General Hydroformylation Procedure

[0215] Examples 1-13 and Comparative Examples 1-3 follow the general hydroformylation procedure. In the general hydroformylation procedure, solvent 2 (20 mL) was loaded into the reactor and aerated overnight with N2. Then a stock solution of rhodium (final concentration of 50 ppm Rh, as Rh (acac) (CO)2 was introduced) and a specific ligand (type and equivalent as defined in Table 6 below) was added, and the resulting solution was aerated for 3 to 4 hours with 1:1 synthesis gas to produce an active Rh (ligand) dicarbonyl hydride catalyst material, and to remove the top toluene. Then the hydroformylation reaction was initiated under 50 psi CO, 50 psi H2 and 3 psi to 5 psi olefins (total pressure was 165 psia; the remainder was made up of N2). The summary of the initial rate and regioselectivity (N:I) measured during the first 3 to 4 days of operation is shown in Table 6.

[0216] Catalyst Stability: For each of Examples 1-13 and Comparative Examples 1-3, the general hydroformylation procedure was run continuously for about one week to determine catalyst stability. The rate / olefin was plotted against time; the slope of the resulting line provides a quantitative measure of deactivation. A slope of zero indicates no catalyst deactivation; the more negative the slope, the faster the deactivation rate, which is undesirable.

[0217] Table 6: Examples 1-13 and Comparative Examples 1-3

[0218] Ligand ID (external) Ligand: Rh molar equivalent Initial rate / olefin N:I <![CDATA[Deactivation rate (slope) b > L1 1.5:1 0.054 66 -0.0026 L2 1.5:1 0.092 94 -0.005 L3 1.5:1 0.075 90 -0.0002 L4 1.5:1 0.0709 80 -0.00007 L5 1.5:1 0.085 90 -0.0019 L6 2:1 0.133 88 -0.0054 L7 1.5:1 0.1112 90 -0.0073 L8 1.5:1 0.07 65 -0.0003 L9 1.5:1 0.11 79 -0.0047 L10 1.5:1 0.085 65 -0.002 L11 1.5:1 0.0124 63 -0.0001 L12 1.5:1 0.06 20 -0.0027 L13 2:1 0.0797 92 0.0012 CL1 1.5:1 0.0992 82 -0.0087 CL2 1.5:1 0.17 40 -0.027 CL3 3:1 0.21 58 -0.021

[0219] Table 7 - Abbreviations

[0220]

[0221]

[0222] Issues to be resolved :

[0223] The lack of a good catalyst system poses a major challenge to the commercialization of the hydroformylation process of olefins. Previously proposed processes have one or more of the following disadvantages: slow reaction rate, low linear selectivity, high catalyst loading, poor stability of the continuous process. Poor stability leads to deactivation in the continuous process, which then leads to low production capacity; replacement of the catalyst increases costs due to the high price of rhodium.

[0224] The hydroformylation process of the present invention provides one or more benefits over previously proposed processes; namely, faster reaction rates, improved selectivity, improved stability, and lower catalyst loadings to achieve these.

Claims

1. An indole-functionalized bisphosphoramidite having a chemical formula selected from the group consisting of: C1) C2) and C3) in R 1 To R 42 are each independently selected from H, a hydrocarbon group, a heteroaryl group, a halogen atom or a heterohydrocarbon group, provided that R 35 To R 42 At least one of is not H; Y 1 To Y 12 Each of which is an independently selected indole group of formula (I): Where R 43 To R 47 Each of is an independently selected atom or group selected from the group consisting of H, alkyl, aryl, heteroaryl, alkoxy, acyl, carboxyl, carboxylate, cyano, -SO 3 H, sulfonate, amino, trifluoromethyl, halogen, a group of the following formula (II), and combinations thereof; provided that i)R 44 To R 47 Two or more of may optionally be bonded together to give one or more cyclic moieties; and ii) In Y 1 To Y 4 , Y 5 To Y 8 and Y 9 To Y 12 In at least one of each of a) R 43 To R 47 At least one of the compounds has the formula (II) Where R 48 To R 52 each of which is an independently selected atom or group selected from H, alkyl, aryl, and alkoxy; or b) R 44 To R 47 Two or more of are bonded together to give one or more cyclic moieties; and iii) when the indole-functionalized bisphosphoramidite has the formula C1), Y 1 To Y 4 At least one of the R 44 To R 46 At least one of them has formula (II).

2. The indole-functionalized bisphosphoramidite according to claim 1, wherein formula (II) is selected from the group consisting of:

3. The indole-functionalized bisphosphoramidite according to claim 1 or 2, wherein In formula C1), R 1 To R 20 Each of is H; In formula C2), R 21 To R 34 Each of is H; and In formula (C3), R 35 and R 42 Each of is H, and R 36 To R 41 Each of is methyl.

4. An indole functionalized bisphosphoramidite according to any preceding claim, wherein precondition (ii)(a) is true, and wherein R 44 To R 46 At least one of them has formula (II).

5. An indole functionalized bisphosphoramidite according to any preceding claim, wherein precondition (ii)(a) is true, and wherein R 45 and / or R 46 One of them has formula (II).

6. The indole functionalized bisphosphoramidite according to claim 1, wherein the indole functionalized bisphosphoramidite is selected from the group consisting of: L1) 2,2'-bis((bis(6-mesityl-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L2) 2,2'-bis((bis(6-(3,5-dimethylphenyl)-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L3) 2,2'-bis((bis(6-(3,5-di-tert-butylphenyl)-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L4) 2,2'-bis((bis(6-([1,1':3',1"-terphenyl]-5'-yl)-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L5) 2,2'-bis((bis(6-([1,1':3',1"-terphenyl]-5'-yl)-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L6) 2,2'-bis((bis(6-(4-tert-butylphenyl)-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L7) 2,2'-bis((bis(6-(4-methoxyphenyl)-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L8) 2,2'-bis((bis(5-(3,5-di-tert-butylphenyl)-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L9) 2,2'-bis((bis(4-(3,5-di-tert-butylphenyl)-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; L10) 1,1',1",1"'-(((4,4',5,5',6,6'-hexamethyl-[1,1'-biphenyl]-2,2'-diyl)bis(oxy))bis(phosphanetriyl))tetrakis(6-(3,5-di-tert-butylphenyl)-1H-indole); L11) 4,4'-bis((bis(6-(3,5-di-tert-butylphenyl)-1H-indol-1-yl)phosphinyl)oxy)-1,1',3,3'-tetrahydro-2,2'-spirobi[indene]; L12) 2,2'-bis(((7,8-dihydrocyclopenta[g]indol-1(6H)-yl)(1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl; and L13) 2,2'-bis((bis(6-(3,5-di-tert-butylphenyl)-3-methyl-1H-indol-1-yl)phosphinyl)oxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl.

7. A method for preparing a rhodium-ligand complex, the method comprising: include: 1) combining starting materials, the starting materials comprising (I) a rhodium catalyst precursor, and (II) an indole-functionalized bisphosphoramidite according to any one of claims 1 to 7, and optionally, (III) a solvent.

8. The method according to claim 6, wherein the rhodium catalyst precursor is selected from the group consisting of: Rh 2 O 3 , Rh 4 (CO) 12 , Rh 6 (CO) 16 and Rh(NO 3 ) 3 .

9. The method according to claim 7 or 8, wherein the rhodium-ligand complex has a ligand / Rh molar ratio of 1 / 1 to 10 / 1. 10 . A rhodium-ligand complex prepared by the method according to claim 7 .